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ABSTRACT 
 
Natalie Rios Herr 
 
 
A LOCALIZED, QUANTITATIVE DRUG DELIVERY TOOL FOR 
NEUROTRANSMISSION STUDIES 
 
(under the direction of R. Mark Wightman) 
 
 
 Iontophoresis is the movement of charged molecules in solution under applied 
current using pulled multibarrel glass capillaries drawn to a sharp tip.  The technique is 
commonly used in neuroscience as a localized drug delivery tool to target select brain 
regions.  A major limitation of the technique is its non-quantitative nature and inherent 
variability between probes.  In this dissertation, iontophoretic delivery has been coupled 
to fast-scan cyclic voltammetry for real-time monitoring of ejections.  The ejection of 
charged and neutral species has been characterized with carbon-fiber microelectrodes 
coupled to iontophoresis barrels to reveal the mechanisms underlying drug delivery: 
iontophoretic and electroosmotic forces.  With the use of the neutral, electroactive 
molecule 2-(4-nitrophenoxy) ethanol (NPE), which is only transported by electroosmotic 
flow (EOF), electroosmosis (EO) was identified as the major contributor to observed 
variability from probe to probe.  In addition, differences in mobility for charged 
compounds were positively correlated to differences in electrophoretic mobility as 
determined by capillary electrophoresis (CE).  Thus, CE can be used to predict the rate 
of transport for compounds that cannot be electrochemically monitored. With this 
information, quantitative iontophoresis is possible for electrochemically inactive drugs by 
using a marker molecule.  This approach was validated in vivo in a well-understood 
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biological system.  Carbon-fiber/iontophoresis probes were used to measure and 
modulate electrically evoked dopamine release in the striatum of anesthetized rats.  
Dopamine release in this brain region is highly regulated by autoreceptors and the 
dopamine transporter.  Iontophoretic ejections of an autoreceptor antagonist and a 
dopamine transporter inhibitor demonstrate that this technique can be used to locally 
modulate presynaptic release.  Additionally, the experiments demonstrate that use of an 
internal marker molecule do not interfere with the biological results.  The final chapters of 
this dissertation focus on the use of quantitative iontophoresis in novel applications, such 
as presynaptic regulation of norepinephrine and dopaminergic signaling in awake 
animals performing behaviors related to drug addiction. 
  
iv 
 
 
ACKNOWLEDGEMENTS 
 They say it takes a village to raise a child, and certainly the same can be said for 
completing a dissertation.  I am thankful that I found such a village to help me make this 
body of work possible.  I would like to start by thanking my advisor, Mark Wightman, for 
his guidance, support, and encouragement throughout the past five years.  His depth of 
knowledge and enthusiasm for discovery has been instrumental to my development as a 
scientist, and I certainly look forward to our continued interactions as I pursue my own 
scientific career.  I would like to give a special thanks to Dr. Andrew Seipel for providing 
me the initial iontophoresis training that laid the foundation for the work presented in this 
dissertation.  I am also thankful for my collaborators from the Wightman lab that have 
contributed to various aspects of this work.  Kevin B. Daniel, an honors undergraduate 
student that I had the pleasure of mentoring, provided experimental help for Chapters 2 
and 3.  Anna M. Belle, the lucky girl accepting my iontophoresis baton, helped with 
Chapter 3.  Dr. Jinwoo Park and Dr. Zoe McElligott performed some of the experiments 
presented in Chapter 4.  Finally, Dr. Catarina Owesson-White was my collaborator on 
the freely-moving experiments presented in Chapter 5.  I would also like to acknowledge 
help from the UNC Electronics Facility and the UNC Physics Machine Shop, as well as 
funding from the NIH, Society for Neuroscience, and NSF. 
 In addition to being my collaborators, current and past members of the Wightman 
have been my friends throughout this process, and I am sincerely grateful for having had 
the opportunity to work with such a great group of people.  I am especially thankful to 
have met Leslie Sombers, Parastoo Hashemi, Zoe McElligott, Catarina Owesson-White, 
v 
 
and Paul Walsh. You all have given me an unconditional friendship which has been key 
to the completion of this dissertation, so Thank You! 
 Finally, to my family:  thank you for the years of support and encouragement you 
have given me.  To my mother, thank you instilling in me an appreciation for hard work, 
education, good morals, and love of family and friends.  To my father, thank you for 
teaching me to approach life with curiosity, and to find ways to make things better.  To 
my mother-in-law, Ilene, and grandma, Sandy, thank you for accepting me so 
wholeheartedly into your family, and being such supporters of me.   
 And to my biggest supporter, the one that I so eagerly embarked on this graduate 
school ride with, my husband Joshua Herr: can you believe it’s over?  I can.  And as I 
think back on the past 5 years, and then the past 9 years, I know that I owe a great deal 
to you.  You have an incredible ability to make me realize that things can be taken one 
step at a time, and that with your support, and that of our friends, great things are 
possible.  I look forward to our next ride, and the ones after that, and know that just how 
you helped us through this ride, you’ll be there to support, encourage, and guide us 
through the rest! 
  
vi 
 
TABLE OF CONTENTS 
List of Tables……………………………………………………………………………………..xii 
 
List of Figures…………………………………………………………………………………...xiv 
 
List of Abbreviations and Symbols…………………………………………………………....xvi 
 
Chapter 1: Iontophoresis and its contribution to the study of neurotransmission1 
Part 1: Iontophoresis ............................................................................................. 2 
Basic principles of iontophoresis ............................................................... 2 
Origin of iontophoresis in neurobiology ..................................................... 5 
Studies on the neuromuscular junction and the initial development 
of iontophoresis ......................................................................................... 7 
Iontophoresis in the central nervous system ............................................. 8 
Quantification of iontophoretic drug delivery ............................................. 9 
Specific aim 1 .......................................................................................... 14 
Specific aim 2 .......................................................................................... 14 
Part II: Introduction to neurotransmission of dopamine and norepinephrine ....... 15 
Dopamine neurotransmission .................................................................. 19 
Specific Aim 3 .......................................................................................... 26 
Norepinephrine neurotransmission .......................................................... 26 
Specific Aim 4 .......................................................................................... 28 
Overview of dissertation ...................................................................................... 28 
References .......................................................................................................... 29 
Chapter 2:  Electroosmotic flow and its contribution to iontophoretic delivery ................ 33 
vii 
 
Introduction .......................................................................................................... 33 
Materials and Methods ........................................................................................ 36 
Chemicals. ............................................................................................... 36 
Iontophoresis Probes. .............................................................................. 36 
Data Acquisition. ...................................................................................... 37 
Iontophoresis Ejections. .......................................................................... 39 
Flow Injection Apparatus. ........................................................................ 39 
HPLC Experiments. ................................................................................. 40 
Capillary Electrophoresis Experiments. ................................................... 40 
Results and Discussion ....................................................................................... 41 
Construction of carbon-fiber iontophoresis probes. ................................. 41 
Quantitative iontophoresis of electroactive compounds. ......................... 42 
Variability in iontophoresis. ...................................................................... 44 
Quantification of electroosmosis and migration. ...................................... 49 
Effects of retaining currents. .................................................................... 53 
Considerations for in vivo use. ................................................................ 55 
Conclusions. ........................................................................................................ 55 
References .......................................................................................................... 57 
Chapter 3.  Probing Pre-synaptic Regulation of Dopamine Release with 
Iontophoresis ....................................................................................................... 60 
Introduction .......................................................................................................... 60 
Materials and Methods ........................................................................................ 62 
viii 
 
Chemicals. ............................................................................................... 62 
Animals and surgery. ............................................................................... 63 
Electrical Stimulation. .............................................................................. 63 
Iontophoresis Probes. .............................................................................. 63 
Electrochemical Data Acquisition and Presentation. ............................... 64 
Iontophoresis Ejections. .......................................................................... 65 
Calibrations. ............................................................................................. 66 
Capillary Electrophoresis Experiments. ................................................... 66 
Histology. ................................................................................................. 67 
Results and Discussion ....................................................................................... 67 
Characterization of iontophoretic delivery in vivo .................................... 67 
Effects of EOF marker on stimulated dopamine release ......................... 70 
Current artifacts on stimulated dopamine release ................................... 72 
Marking of electrode placement by iontophoresis of a dye ..................... 73 
Quantitative iontophoresis of non-electroactive drugs ............................. 76 
Modulation of neurotransmitter release using quantitative 
iontophoresis ........................................................................................... 79 
Modulation of other dopaminergic presynaptic processes ...................... 83 
Rapid modulation of dopamine release and uptake ................................ 86 
Conclusions ......................................................................................................... 87 
References .......................................................................................................... 88 
ix 
 
Chapter 4.  Electrochemical Monitoring of Norepinephrine and Dopamine in 
Subregions of Bed Nucleus of the Stria Terminalis ......................................................... 92 
Introduction .......................................................................................................... 92 
Materials and Methods ........................................................................................ 95 
Chemicals and drugs ............................................................................... 95 
Animals and surgery ................................................................................ 95 
Electrical Stimulation ............................................................................... 96 
Iontophoresis Probes ............................................................................... 96 
Electrochemical Data Acquisition and Presentation ................................ 97 
Iontophoresis Ejections ........................................................................... 97 
Calibrations .............................................................................................. 98 
Capillary Electrophoresis Experiments .................................................... 98 
Histology .................................................................................................. 99 
Results and Discussion ....................................................................................... 99 
Catecholamine detection within the BNST .............................................. 99 
Pharmacological evidence for NE in the ventral BNST and DA in 
the dorsolateral BNST ........................................................................... 101 
Time course of catecholamine response within the BNST .................... 103 
Local regulation of norepinephrine release in the BNST with 
quantitative iontophoresis ...................................................................... 106 
Iontophoresis of acetaminophen has no effect on NE release in 
the medial BNST ................................................................................... 106 
x 
 
Quantification of iontophoretic delivery of electroinactive NE drugs ...... 107 
Iontophoresis of NE drugs in dorsal and ventral portions of the 
medial BNST ......................................................................................... 109 
The dorsal and ventral portions of the BNST are differentially 
modulated by iontophoresis of desipramine and idazoxan .................... 112 
Iontophoresis as a diagnostic tool for the identification of 
catecholamine signals ........................................................................... 113 
Conclusions ....................................................................................................... 114 
References ........................................................................................................ 115 
Chapter 5.  Adaptation of quantitative iontophoresis to study neurotransmission 
during reward-seeking behaviors ...................................................................... 117 
Introduction ........................................................................................................ 117 
Experimental methods ....................................................................................... 120 
Animals and surgery .............................................................................. 120 
ICSS ...................................................................................................... 120 
Iontophoresis Probes ............................................................................. 121 
Iontophoresis Ejections ......................................................................... 122 
Results .............................................................................................................. 123 
Improvements to carbon-fiber iontophoresis probe construction ........... 123 
Modification to BAS guide cannula and Biela manipulator .................... 124 
Modulation of DA release in awake, non-behaving animals using 
quantitative iontophoresis ...................................................................... 131 
xi 
 
Effects of raclopride on reward-related DA release ............................... 134 
Conclusions and future directions ......................................................... 137 
References ........................................................................................................ 139 
 
 
 
 
  
xii 
 
LIST OF TABLES 
Table           Page 
2.1 Rate of iontophoretic delivery of charged compounds relative to EOF as 
measured by FSCV ………………………………………….............................. 51
3.1 Effect of iontophoresis on the sensitivity of carbon-fiber microelectrodes for 
dopamine detection ….…………………………………………………………… 79
. 
  
xiii 
 
LIST OF FIGURES 
Figure           Page 
1.1 
Schematic diagram of an iontophoretic barrel containing a salt solution of 
X+Y-.………………………………………….................................................... 4 
1.2 
Effect of iontophoresis on the sensitivity of carbon-fiber microelectrodes for 
dopamine detection ….…………………………………………………………... 16 
1.3 Synthesis of catecholamine neurotransmitters………………………………... 17 
1.4 Drawing of a dopamine synapse………………………………………………... 18 
1.5 Targets of DA signaling in the striatum……………………………………….... 23 
2.1 SEM images and schematic of carbon-fiber iontophoresis probe……………  37 
2.2 Analysis of consecutive iontophoretic ejections of dopamine………………..   42 
2.3 
Analysis of consecutive iontophoretic ejections of a neutral marker 
compound, NPE………………………………………………………………… 44 
2.4 Analysis of consecutive iontophoretic ejections of dopamine and NPE…….   45 
2.5 Variability of iontophoretic ejections for different barrels……………………...  47 
2.6 Correlation between iontophoretic and electrophoretic mobility……………..   50 
2.7 Effects of retention current on iontophoretic ejections………………………...  53 
3.1 Temporal profile of consecutive iontophoretic ejections……………………… 68 
3.2 Effect of AP on stimulated dopamine release…………………………………. 70 
3.3 Effect of saline on stimulated dopamine release……………………………… 73 
3.4 
Confirmation of electrode placement into the striatum using iontophoresis 
of pontamine sky blue dye……………………………………………………….. 74 
3.5 Chemical structures of compounds used for study…………………………… 76 
3.6 
Correlation of electrophoretic mobility to iontophoretic transport rate for 
dopamine drugs…………………………………………………………………… 77 
3.7 
Stimulated dopamine release in an anesthetized animal before and after a 
localized ejection of solution containing both AP and quinpirole…………….  81 
3.8 
Stimulated dopamine release in an anesthetized animal before and after a 
localized ejection of solution containing both AP and nomifensine…………. 83 
   
xiv 
 
3.9 Rapid modulation of DA autoreceptors using quinpirole and raclopride and 
dopamine transporter using nomifensine……………………………………….  
84 
4.1 Anatomical location of BNST subnuclei………………………………………... 94 
4.2 
Anatomical mapping of catecholamine releasing sites in the medial and 
lateral BNST………………………………………………………………………. 100
4.3 Cyclic voltammograms of dopamine and norepinephrine……………………. 102
4.4 Identification of catecholamine signals with pharmacology…………………..   104
4.5 NE and DA show different rise times after electrical stimulation……………..  105
4.6 Effect of AP on stimulated NE release in the vBNST…………………………. 108
4.7 
Correlation of electrophoretic mobility to iontophoretic transport rate for 
norepinephrine drugs…………………………………………………………….. 110
4.8 
Stimulated NE release before and after a localized ejection of solution 
containing both AP and idazaxon……………………………………………….. 111
5.1 Electrical cross-talk from iontophoresis current……………………………….. 125
5.2 
Intracerebral guide cannulae used for experiments with awake and 
behaving animals………………………………………………………………….   127
5.3 Manipulator from Crist Instruments for iontophoresis probes………………...  128
5.4 Machined piece to couple Biela manipulator to intracerebral guide cannula.   130
5.5 
Stimulated dopamine release in an awake animal at rest before and after a 
localized ejection of solution containing both AP and raclopride……………. 132
5.6 Time course of raclopride effect in an awake animal at rest…………………. 133
5.7 Timing diagram and corresponding increases in DA release during ICSS…   135
5.8 Increase in dopamine signal due to cue and lever presentation……………..  136
 
  
xv 
 
LIST OF ABBREVIATIONS AND SYMBOLS 
A/D   analog to digital 
ACh   acetylcholine 
AP   acetaminophen 
AP   anterior-posterior 
BNST   bed nucleus of the stria terminalis 
C   coulomb 
CE   capillary electrophoresis 
CNS   central nervous system 
D/A   digital to analog 
DA   dopamine 
[DA]max   maximal dopamine overflow 
DAT   dopamine transporter 
DC   direct current 
dl   dorsolateral 
dm   dorsomedial 
DMI   desipramine 
DOPA   3,4-dihydroxyphenylalanine 
DV   dorsal-ventral 
E    applied electric-field,  
EC5o   concentration to obtain 50% maximal effect 
EO   electroosmosis 
EOF   electroosmotic flow 
EPI   epinephrine 
xvi 
 
F   Faraday’s constant (96,485 C/mol) 
FSCV   fast-scan cyclic voltammetry 
GABA   -aminobutyric acid 
HPLC   high pressure liquid chromatography 
HQ   hydroquinone 
Hz   hertz 
i   current (A) 
i.p.   intraperiotoneal injection 
ICSS   intracranial self-stimulation 
IDA   idazoxan 
kg   kilogram 
L   distance from the inlet to the detection point 
LC   locus coeruleus 
Lt   total length of capillary 
M   molar 
M   moles (iontophoretic flux) 
MFB   medial forebrain bundle 
mg   milligram 
min   minutes 
ML   medial-lateral 
mm   millimeter 
mM   millimolar 
ms   millisecond 
µA   microamperes 
xvii 
 
µm   micrometer 
MSN   medium spiny neuron 
N   nomifensine 
n   transport number 
nA   nanoamperes 
NAc   nucleus accumbens 
NE   norepinephrine 
NET   norepinephrine transporter 
nM   nanomolar 
NPE   2-(4-nitrophenoxy) ethanol 
PEEK   polyetheretherketone 
q   iontophoretic flux 
Q   quinpirole 
qD   diffusional efflux 
R   raclopride 
s   seconds 
SEM   scanning electron microscopy 
t   time 
t1/2   time required for signal to decay 50% 
tr   retention time 
TRIS   tris(hydroxymethyl)aminomethane buffer 
UA   uric acid 
UV   ultra violet 
v   ventral 
xviii 
 
V   volts 
vm   ventral medial 
VTA   ventral tegmental area 
z   valence charge 
ε   permittivity 
ζ    zeta-potential formed at the glass capillary-solution interface  
veo   velocity of electroosmotic flow  
vep    rate of migration 
vobs   observed linear velocity 
η    solution viscosity 
µeo    electroosmotic mobility 
µep   electrophoretic mobility 
 
 
 
 
 
Chapter 1 
 
Iontophoresis and its contribution to the study of neurotransmission 
 
Iontophoresis, also known as ionophoresis and microelectrophoresis, is the 
movement of ions and molecules under the influence of an applied current.  The 
capillaries used for this technique are pulled to a fine tip making them ideal for localized 
ejection of drugs in biological systems.  Iontophoresis has found a niche in neuroscience 
for the local application of neurotransmitters and drugs to discrete brain regions.  It offers 
significant advantages over other drug delivery methods such as systemic injections, 
microinjection, and pressure ejection.  For example, when a drug is administered 
systemically it non-selectively targets all regions of the brain possibly activating neuronal 
circuitry not under study, and thus confounding interpretation of the measured results.  
Additionally, metabolism of drugs in the periphery can reduce the drug’s effects in the 
brain, and some drugs are unable to pass the blood-brain barrier (Stone, 1985).  
Microinjection and pressure ejection are two localized drug delivery tools which 
overcome the above disadvantages of systemic injections, but suffer from their own 
limitations.  When compared to iontophoresis, microinjection and pressure ejection offer 
much less control over drug delivery, show problems with diffusive leakage, and the 
volume associated with delivery often causes damage to the tissue (Curtis and Nastuk, 
1964).  Iontophoresis offers fine control of drug delivery; diffusive leakage can be 
controlled with retaining currents (or by using high resistance pipettes) and tissue 
damage is minimal because there is little volume associated with the ejection. The 
technique is not, however, without disadvantages, and chief among them is the inability 
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to quantify drug delivery.  The experiments carried out in this dissertation are aimed at 
eliminating these disadvantages and applying iontophoresis to the quantitative study of 
dopaminergic and norepinephrine neurotransmission in the rat brain. 
This chapter will be divided into two main sections.  The first will give an 
introduction to the basic principles of iontophoresis, and include an historical account on 
the development of iontophoresis. It will conclude with a summary of previous attempts 
made to quantify drug delivery and how the specific aims in this dissertation have led to 
quantitative iontophoresis.  The second section will focus on neurotransmission of 
dopamine and norepinephrine in the rat brain.  Particular emphasis will be placed on the 
basic principles of dopaminergic and norepinephrine neurotransmission as it related to 
signaling in the striatum and bed nucleus of the stria terminalis (BNST). It will close by 
summarizing the advantages of using iontophoresis and how the development of 
quantitative iontophoresis will facilitate future studies. 
PART 1: IONTOPHORESIS 
Basic principles of iontophoresis 
Iontophoretic drug delivery relies on the movement of ions under the influence of 
an applied current.  Single or multi-barrel glass pipettes are pulled to a sharp tip, where 
each barrel is about 1 µm in diameter.   Individual barrels are loaded with a drug solution 
prepared in NaCl to ensure adequate ion flow and an outward current is applied to a 
glass capillary. A potential difference is established between the ejecting solution and 
the outside buffer such that ions move in the direction opposite their charge.  If a positive 
current is applied to the capillary, cations will be ejected out of the pipette; similarly, if a 
negative current is applied, anions will be ejected out of the pipette (Curtis and Nastuk, 
1964; Stone, 1985).  Figure 1.1 shows a schematic diagram of an iontophoresis probe 
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containing ions X+ and Y-.  In the right panel, a positive current is applied to the barrel, 
causing X+ to be ejected into solution, and Y- to be retained.  A negative current is 
applied to the barrel on the left panel, and the ions move in opposite directions to that 
shown in the right panel.   
In addition to the movement of ions due to the application of a current, there is 
also a significant contribution from electroosmosis (EO), as will be described in detail in 
Chapter 2.  Transport by EO is due to the presence of an electrical double-layer on the 
surface of the glass capillaries.  The glass surface has negative charges on it which 
attract positive charges.  When a potential is applied to the glass capillary, the cations on 
the surface are attracted to the anode.  When a positive current is applied to the 
capillary, the bulk of the solution will move out of the capillary, carrying with it cations, 
anions, and neutrals alike.  Since this a bulk flow of solution, charged molecules as well 
as neutral molecules are transported with equal efficiency, unlike when transport is due 
to the migration of ions.  To accurately describe drug delivery by iontophoresis, a 
distinction must be made between transport that is due to the migration of ions and that 
due to bulk flow.  In this dissertation, the migration of ions will be termed electrophoretic 
and the movement due to bulk flow will be termed electroosmotic.  Thus, observed 
iontophoresis ejections are due the combination of electrophoretic and electroosmotic 
processes. 
Iontophoresis probes are normally constructed from multi-barrel glass, allowing 
one of the barrels to serve as a recording electrode.  In some cases the barrel is filled 
with 4-5 mM NaCl and is used to measure voltage changes in response to the 
application of a drug.  For in vitro preparations, such as that of the neuromuscular 
junction, fluctuations in membrane potentials are measured.  Measurements by the 
recording electrode in the CNS are usually of the electrical properties of single neurons,  
4 
 
 
Figure 1.1  Schematic diagram of an iontophoretic barrel containing a salt solution of 
X+Y-.  (A) Positive current is applied to the solution to initiate migration of cations (X+) 
out of the barrel.  (B) A negative current is applied to retain cations (X+), and thus control 
diffusive leakage.  A negative current may also be used to eject a drug which is an anion 
(Y-) in solution.   
  
Y-
X+ X+
X+
X+
X+
X+
+
X+
X+
Y- Y-
Y-
Y-
Y-
Y-
+
Y-
(A) (B)
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with a technique known as extracellular single-unit recordings.  Fine metal wires (few 
microns in diameter) are normally used for extracellular single-unit recordings, and in 
this case, the wire is inserted into the center barrel and insulated by the surrounding 
glass.  Tungsten and platinum alloys are the most common types of metal used for these 
measurements.  The coupling of a recording electrode to multiple iontophoresis probes 
allows for quick comparison of the differences or similarities in the measured results due 
to the application different drugs. 
Origin of iontophoresis in neurobiology 
Modern neurobiology, as it is studied today, relies on three unifying principles.  
The oldest and most established principle stems from the work of the neuroanatomist 
Santiago Ramon y Cajal and is called the “neuron doctrine.”  This work established the 
anatomical significance of neurons, showing that neurons are cells, with dendrites, 
axons, and cell bodies that contain a nucleus.  Additionally, it showed that neurons form 
specialized connections (termed synapses by Sherrington) with other neurons, and that 
the location and nature of these connections is indicative of the function of a neuron.  
The electrical properties of neurons are the basis of the second important principle for 
studying neurons.  Alan Hodgkin and Andrew Huxley’s seminal experiments in squid 
giant axons led to the discovery that rapid potential changes at a cell body propagate 
down an axon to communicate with other neurons downstream.  This signal, called an 
action potential, relies on the opening and closing of ion channels located on neurons, 
and is a very fast form of communication between neurons.  The final principle is that of 
chemical synaptic transmission.  After an action potential propagates down an axon, 
chemical messengers, termed neurotransmitters, are released which interact with 
receptors on other neurons.  This form of neuronal communication was best 
demonstrated by the work of Otto Loewi and Sir Henry Dale, who showed that when the 
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vagus nerve of the frog heart is stimulated it releases chemicals that when put on a non-
innervated heart exert the same physiological changes as the stimulation.  Later work 
established that acetylcholine (ACh) was responsible for the observed effects, and it was 
noted as the first discovered neurotransmitter.   
This discovery led to major changes in the study of neurobiology, as scientist 
became interested in identifying new neurotransmitters and understanding the functional 
actions of neurotransmitters.  It also led to years of heated debates regarding whether 
synaptic transmission was chemical or electrical in nature.  The division between the two 
camps has become known as the “soup versus spark” controversy, and lasted roughly 
from 1936 to 1952.  Mounting evidence in support of the chemical hypothesis culminated 
with the finding that synaptic inhibition was mediated chemically by Sir John Eccles, a 
key proponent of the electrical hypothesis.  At this time it became widely accepted that 
synaptic transmission was chemically mediated, although, later experiments showed that 
at some cells, electrical transmission occurs.  Nonetheless, chemical synaptic 
transmission, termed neurotransmission henceforth, is the dominating mechanism for 
neuronal communication, and much research since the 1950s has focused on 
understanding its principles.   
Research on neurotransmission during the years following the “soup versus 
spark” controversy focused on the actions of ACh at the frog neuromuscular junction, 
and how the release of ACh affected the muscle’s permeability to different ions.  
Experiments were carried out in which ACh was applied to the junction by perfusion or 
diffusion from a microelectrode.  However, it was quickly accepted that this form of ACh 
application was too slow and crude to accurately correlate to the synaptic release of 
ACh.  A need grew for a method to deliver ACh to the junctions locally and quickly.  In 
1953, William Nastuk published what is widely accepted to be the first account of 
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iontophoresis (Hicks, 1984).  The paper describes the use of pulled glass capillaries 
filled with ACh that were electrically controlled to deliver ACh directly onto the 
neuromuscular junction.  A recording electrode was placed in close proximity to the 
pulled glass capillary to measure changes in membrane potential. The work showed that 
as the pipette approached the end-plate region of the neuromuscular junction, 
depolarization slowly occurred.  It also showed that application of a positive current to 
the barrels caused the muscle to depolarize and application of a negative current 
repolarized the muscle (Nastuk, 1953).  From these experiments, iontophoresis was 
born, and later refined by del Castillo and Katz (Del Castillo and Katz, 1955).  
Studies on the neuromuscular junction and the initial development of 
iontophoresis 
It was suspected (and supported by indirect findings) that along the 
neuromuscular junction the end-plate regions would respond with increased sensitivity to 
ACh as compared to nerve-free regions.  The development of iontophoresis made direct 
testing of this hypothesis possible, and del Castillo and Katz published a paper 
definitively showing that end-plate regions were more responsive to iontophoretic 
application of ACh than nerve-free regions (Del Castillo and Katz, 1955).  Additionally, 
they showed that intracellular application of ACh caused no effect, leading them to 
conclude that receptors are located only on the outer surface of the end-plate.  These 
experiments not only provided valuable insight to the mechanisms of ACh at 
neuromuscular junctions, but also introduced other researchers to the advantages of 
iontophoresis and its usefulness for mapping end-plate potentials (Axelsson and 
Thesleff, 1959; Miledi, 1960; Katz and Miledi, 1964; Peper and McMahan, 1972). 
Del Castillo and Katz continued their studies, and published a series of papers 
describing both advances on the understanding of how ACh (and its agonists and 
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antagonists) acted at the neuromuscular junction, and how iontophoresis was used in 
these studies (Del Castillo and Katz, 1956, 1957a, b, c; Del Castillo and Katz, 1957d).  
The body of this work opened up a whole new area of research using iontophoresis, and 
it was soon expanded to the CNS and other families of neurotransmitters. 
Iontophoresis in the central nervous system 
The technique of iontophoresis as it is used today is essentially the same as that 
described in the paper by David Curtis and Rosamund Eccles, which is the first account 
of using iontophoresis in the CNS.  Using five-barrel pipettes pulled to a fine tip, they 
loaded four of the barrels with drugs, and the central barrel, filled with 4M NaCl, served 
as the recording electrode.  Each barrel was individually controlled, with positive currents 
applied to cause ejection and retaining currents applied in between ejections to minimize 
leakage effects.  Importantly, they determined that Renshaw cells can be locally 
modulated by iontophoresis, and that there is a differential response between some 
drugs when administered systemically versus iontophoretically.  This led them to the 
conclusion that the blood-brain barrier may have been causing some drugs to seem 
unresponsive, and that by using iontophoresis this problem was circumvented since 
application occurs directly onto the receptor sites (Curtis and Eccles, 1958). 
From 1960s into the 1980s, largely thanks to the papers published by Curtis, 
iontophoresis was increasingly used in the CNS to study the pharmacological activity of 
various drugs at cells in specific brain regions.  Research quickly moved beyond 
studying ACh and into studying all known neurotransmitters and the receptors that they 
activate.  There was particular interest in sensitivity variations from cell to cell, 
pharmacology of new antagonists, and the mechanism of action.  Some of the most 
commonly studied neurotransmitters with iontophoresis include glutamate, GABA, 
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acetylcholine, norepinephrine, dopamine, and serotonin.  Part 2 of this chapter will 
discuss neurotransmission of dopamine and norepinephrine. 
Quantification of iontophoretic drug delivery 
Early on, from del Castillo and Katz’s very first papers on iontophoresis, a critical 
analysis of the practical considerations necessary to use the technique effectively had 
taken place.  The advantages of the technique were immediately apparent: it allows for 
rapid and local application of ACh, easily simulating the actions of synaptic ACh release 
to map receptor distributions.  They also, however, noted the drawbacks, chiefly that an 
incomplete understanding of how drug delivery occurred made it difficult to interpret 
some of the results.  In their own words, 
“… the time course and amplitude of the potential change varied a great deal, 
depending upon such variable factors as the resistance of the ACh pipette and 
the distribution and accessibility of the receptive spots on the fibre” (Del Castillo 
and Katz, 1955). 
In future papers they noted variability in the electrical properties of the 
iontophoresis barrels (most likely changes in tip resistance) which led to changes in the 
magnitude of current and the distance between the tip and tissue necessary to elicit a 
response with ACh application (Del Castillo and Katz, 1957d).  These same findings 
have been continuously referred to in the literature up to the present-day, and accounts 
for the technique’s eventual decline in popularity (Curtis and Nastuk, 1964; Bradley and 
Candy, 1970; Bloom, 1974; Hicks, 1984).   
Due to the variations observed in neuronal response, a new area of research 
developed focused on understanding how iontophoretic drug delivery occurred.  The first 
efforts were put toward developing a theory that could predict drug ejection, both as it 
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traveled down an iontophoretic barrel and once out of the barrel.   To describe transport 
within the barrel, a modified form of Faraday’s Law was used where the iontophoretic 
flux (moles), M, is defined as: 
Mൌn it
ZF
      (1-1) 
where n is the transport number, i is the current applied (A), t is the ejection time (s), z is 
valence charge, and F is the Faraday constant (96,485 C/mol) (Purves, 1979).  The 
transport number, n, is determined empirically and refers to the percentage of the total 
current that the ion carries during ejection.  From this simple relationship, it is expected 
that the amount of delivered material can be predicted by knowing the transport number 
and the applied current and ejection time, which are controlled by the experimenter.  
Unfortunately, in practice, this is not the case, as great variability in ejection exists from 
barrel to barrel.  This is likely due to additional contributions in delivery from 
electroosmosis which is not included in equation 1, and is the focus on Chapter 2.  
Determination of transport numbers 
Despite the incomplete description of delivery given by equation 1-1, much 
research was focused on determining the transport number for all the neurotransmitters 
and drugs most commonly used.  This was done by measuring the amount of material 
delivered in vitro using a variety of detection schemes, including bioassays, 
electrochemistry, and most commonly, radiolabeling assays (Krnjevic and Phillis, 1963b, 
a; Bradley and Candy, 1970; Purves, 1977; Armstrong-James et al., 1980; Kruk et al., 
1980; Armstrong-James et al., 1981).  The quantities of material detected were highly 
variable from barrel to barrel leading to high variability in re ported transport numbers.  
To account for this, researchers took the average of many electrodes to determine the 
transport number, although different researchers still obtained different transport 
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numbers.  For example, the transport number determined for norepinephrine ranges 
from 0.09 to 0.35 over 6 different published reports (Krnjevic et al., 1963; Bradley and 
Candy, 1970; Hoffer et al., 1971; Barasi and Roberts, 1977; Sasa et al., 1978; Bradshaw 
et al., 1981).  Interestingly, Bradley and Candy found that they obtained significantly 
different transport numbers for 5-hydroxytryptamine (serotonin) when they used small 
versus large tip iontophoresis probes (Bradley and Candy, 1970). This seems indicative 
of the effect electroosmosis and spontaneous diffusion had on the measured transport 
numbers, and highlights the ineffectiveness of equation 1-1.  As will be seen in Chapter 
2, electroosmosis contributes significantly to observed iontophoretic ejections.  
Additionally, increases in tip diameter positively correlate with increases in the amount of 
electroosmosis observed, further suggesting that this mechanism may account for their 
observed variability. 
Effects of retaining currents 
Recognizing that equation 1-1 is an incomplete description of iontophoretic 
transport within the barrel, Purves derived an expression for iontophoretic flux (q) which 
included a factor for what he termed “diffusional efflux, qD” shown in equation 1-2 
(Purves, 1979) 
q= qF
exp൬qFqD
൰-1
            (1-2) 
where qF  is equal to M from equation 1-1.  Although this modified equation still does not 
accurately predict iontophoretic delivery, development of this equation led to a critical 
analysis of retention currents applied in between ejections, which affect diffusional efflux.  
From these studies it was noted that the observed ejection is a function of the magnitude 
of the retention current applied as well as the duration and frequency for which it was 
applied.  A lag in rise-time to reach steady state will be increased with increased 
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retention time and magnitude, highlighting the importance of knowing the “history of the 
pipette” (Purves, 1977, 1979, 1980).  Intuitively, this makes sense, since application of 
current opposite in polarity to the ejecting current will cause ions to migrate up the barrel, 
depleting the solution at the tip of ions for ejection.  Because of this, low retention 
currents are typically applied (5 nA or less of opposite polarity to the ejecting current), 
and often a “warm-up” period is necessary to replenish the solution at the tip of ions.  A 
warm-up period consists of at least 2 or 3 cycles of ejection and retention to achieve fast 
rise and decay time courses during experiments.  The need to reach an equilibrium 
between ejection and retention is crucial considering the nature of the experiments 
typically performed with iontophoresis.  For example, one use of iontophoresis is to 
study receptor-drug interactions, which would be greatly affected by a variable time 
course in drug delivery. 
Other factors affecting iontophoretic delivery 
In addition to transport numbers and diffusional efflux, the literature is laced with 
other factors not included in equations 1-1 or 1-2 that are thought to contribute to 
iontophoretic delivery (Stone, 1985).  Factors such as the concentration of the drug 
solution and the dimensions of the barrels have obvious implications on the observed 
ejection.  The acidity of the drug solution will affect the solubility of the drug, and will also 
affect the amount of EOF since there will be more anions on the glass surface at lower 
pHs.  The concentration of drug in solution and the dimensions of the barrel are not 
expected to affect delivery due to ion migration, but will have a significant effect on 
diffusional efflux and electroosmosis since both cause a bulk flow of solution.  Thus, 
using higher concentrated drug solutions as well as barrels with larger tips, will lead to 
larger observed ejections.   
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Some other factors mentioned include the method used for filling the barrels and 
the age of the constructed electrode.  One can see how these factors may influence 
drug delivery, but not many reports exist which specifically document their effects.  
Additionally, the medium into which compounds are iontophoresed will also affect 
delivery, but this more likely a consequence of transport away from the tip, than the 
ejection itself.  Transport away from the tip has been modeled as diffusion from a point 
source, and factors such as volume fraction and tortuosity of the brain have been 
included (Rice and Nicholson, 1995).  The extracellular volume fraction of the brain is 
given the symbol α, and is defined as the fraction of the total brain volume that is 
extracellular space. In the brain, tortuosity, given the symbol λ, is a measure of how 
much the movement of substances is hindered by cellular components such as cell 
bodies or processes.   
Real-time monitoring of iontophoretic delivery 
Despite the efforts of many researchers, complete understanding of iontophoretic 
delivery has not been achieved.  This is in part due to the complex mechanisms involved 
in delivery that will undoubtedly influence attempts to quantify delivery based on theory.  
For this reason it seems that the best alternative for quantifying iontophoretic drug 
delivery is to monitor drug delivery in real-time.  The pioneering design by Millar and co-
workers couples iontophoretic barrels to carbon-fiber microelectrodes, for real-time 
monitoring of electroactive compounds using fast-scan cyclic voltammetry (Armstrong-
James et al., 1981).  In addition to being able to monitor ejection of electroactive 
compounds, this design is advantageous because the carbon-fiber microelectrode can 
also be used to monitor extracellular single-unit activity, as well as the release of 
electroactive neurotransmitters such as dopamine and norepinephrine.   
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Specific aim 1 
The first aim of this dissertation is to use carbon-fiber iontophoresis probes to 
gain a better understanding of iontophoretic drug delivery, with particular emphasis on 
electroosmosis and iontophoretic variability.  It is hypothesized that inherent variability in 
the construction of iontophoresis barrels leads to variability in electroosmotic flow (EOF), 
ultimately causing variability in the observed iontophoretic ejection.  Furthermore, the 
relative rate of transport of anions or cations, as it compares to transport of a neutral 
EOF marker molecule will remain the same across barrels.  Thus, quantification of 
iontophoretic delivery for electroinactive drugs is possible by monitoring the rate of EOF 
and knowing the relative rate of transport for the drugs which can be obtained by 
capillary electrophoresis.  The results and conclusions for this aim are given in Chapter 
2. 
Specific aim 2 
The second aim of this dissertation is to establish a methodology for quantifying 
the delivery of electroinactive drugs which is compatible with in vivo experiments already 
carried out in the Wightman lab.  To accomplish the goal of this aim it was first 
necessary to test the methodology in a well understood biological system.  For this 
purpose, regulation of dopaminergic autoreceptors and uptake in the striatum of 
urethane anesthetized rats was chosen, since it has been extensively studied in the 
Wightman lab (Garris et al., 1994b; Garris et al., 1994a; Jones et al., 1995; Mickelson et 
al., 1998; Garris et al., 2003; Kita et al., 2007).  Part 2 of this introduction will explain 
dopaminergic neurotransmission and highlight previous findings that will be used to 
confirm functionality of the iontophoresis method.  The results and conclusions from 
these experiments are given in Chapter 3.  
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PART II: INTRODUCTION TO NEUROTRANSMISSION OF DOPAMINE AND NOREPINEPHRINE 
Neurotransmission is the process by which neurons communicate with one 
another, though a combination of electrical and chemical signals.  The basic structure of 
a neuron is shown in Figure 1.2.  A typical neuron is made up of three basic parts: a cell 
body, dendrites, and an axon.  Similar to other cells in the body, a neuron has a cell 
body containing a nucleus and all the essential organelles necessary for cellular 
function.   Unique to neurons is the axon and the elaborate arborization of dendrites that 
originate in the cell body.  Dendrites are responsible for receiving information from other 
neurons, while axons are responsible for sending information.  The transfer of 
information occurs at the synapse, which is where an axon and dendrite meet.  Signals 
are sent through axons in the form of electrical impulses, called action potentials.  At the 
synapse, the axonal ending, called the presynaptic terminal, releases its 
neurotransmitter onto the dendrites of the post-synaptic cell which furthers neuronal 
communication. 
Dopamine (DA) and norepinephrine (NE) belong to a class of neurotransmitters 
called catecholamines which contain a catechol moiety and a side chain of ethyl amine.  
The synthesis of catecholamine neurotransmitters occurs at the terminals of 
catecholamine neurons and is shown in Figure 1.3.  It begins with tyrosine and is 
terminated with either the synthesis of DA, NE, or epinephrine (EPI), depending on the 
specialization of the neuron.  After synthesis, the catecholamines are packaged into 
vesicles for subsequent release into the extracellular space in a Ca2+-dependent process 
which initiates when an action potential depolarizes the presynaptic terminal.  The 
depolarization causes voltage-gated Ca2+ channels to open allowing vesicles to fuse with 
the presynaptic membrane in a process called exocytosis.  In this process, vesicles are 
directed, tethered, and docked to the plasma membrane for a final priming step before  
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Figure 1.3.  Synthesis of catecholamine neurotransmitters.  Catecholamine synthesis 
begins with tyrosine.  Tyrosine hydroxylase is the rate-limiting enzyme in the synthesis of 
catecholamines and is responsible for converting tyrosine to DOPA. Dopamine is 
synthesized from DOPA, and synthesis of norepinephrine and epinephrine occurs from 
dopamine at dendritic terminals. 
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Figure 1.4.  Drawing of a dopamine synapse.  DA terminals synthesize, package, and 
process DA for release.  Upon invasion of an action potential into the DA terminal, 
vesicles fuse with the plasma membrane and release their contents in a Ca2+-dependent 
process called exocytosis.  Once released, DA diffuses across the synaptic cleft (and 
often times outside of the cleft) to reach its targets.  Pre-synaptically, DA release is 
modulated by D2 autoreceptors.  Levels of DA in the extracellular space are regulated 
by the dopamine transporter, which is responsible for recycling DA back into the 
terminal.  Post-synaptically, DA exerts its effects on either D1-like or D2-like receptors. 
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undergoing fusion and release.  Once released, the catecholamine neurotransmitters 
diffuse in the synaptic cleft to reach their target receptors which may be pre or post-
synaptically located.  Figures 1.4 shows the basic structure of a DA synapse.  NE 
synapses contain the same basic elements as the DA synapse, but also contain 
dopamine β-hydroxylase inside vesicles to convert DA to NE.  Instead of DAT and D2 
autoreceptors, NE terminals express the norepinephrine transporter (NET) and α2-
adrenergic autoreceptors.  Post-synaptically they express α- or β-adrenergic receptors.  
Dopamine neurotransmission 
Dopamine is the most abundant catecholamine in the brain and is involved in 
many key functions such as locomotion, learning, cognition, and the processing of 
rewarding stimuli.  It has been extensively implicated in drug addiction due to its 
involvement in motivation and reward.  A common model for studying reward-seeking, 
and by extension drug addiction, is intracranial self-stimulation (ICSS).  In ICSS, animals 
are taught to press a lever to deliver an electrical stimulation to the brain which they find 
rewarding.  These types of experiments established a clear role for DA in reward-
seeking behavior, as animals learn to press quicker and press more frequently for 
stimulations to certain brain regions containing mainly DA neurons (Wise, 2004). 
However, despite decades of DA research on reward, the exact mechanisms by which 
DA influences reward-seeking behavior remain unclear.  Technological advances 
continue to further our understanding of DA neurotransmission, and the work presented 
in this dissertation is aimed at continuing this advancement. 
Tools for studying dopamine neurotransmission in vivo 
Dopamine neurotransmission can be studied either presynaptically at terminals 
that release DA, or post-synaptically at the cells to which DA terminals synapse to.  
Presynaptic release of DA can be studied with a variety of techniques, of which 
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microdialysis and voltammetry are the most common.  Microdialysis is a sampling 
method that relies on the diffusion of small molecules into a dialysis membrane 
implanted in the brain region of interest.  The dialysate, which is the solution removed 
from the brain, is externally analyzed using techniques such as liquid chromatography 
and capillary electrophoresis.  This method of detection offers excellent chemical 
selectivity, and allows multiple analytes to be examined at once.  However, despite 
recent advance, the time-scale of detection (10’s of s) remains much slower than the 
time-scale at which neurotransmitter release occurs (ms) (Robinson et al., 2008; Perry et 
al., 2009).  Due to their catechol moiety, catecholamines are electroactive and can be 
detected at modest potentials.  Electrochemical methods offer increased temporal 
resolution over microdialysis, but less chemical selectivity.  In a recent review, Robinson 
et al discuss the available tools for studying neurotransmission, including the 
advantages and disadvantages of both electrochemical and non-electrochemical 
approaches (Robinson et al., 2008). 
Fast-scan cyclic voltammetry at carbon-fiber microelectrodes has emerged as 
the preferred electrochemical tool for in vivo monitoring of dopamine.  Carbon-fiber 
microelectrodes consist of a glass-encased carbon fiber that is ~5 µm in diameter and 
cut to a length of 50-100 µm.  The small dimensions of the probe limit the tissue damage 
caused by implantation, and allow for mapping of microenviornments within brain 
regions (Wightman et al., 2007).  In the experiments presented in this dissertation, a 
triangular waveform from -0.4 V to +1.3 V, versus a Ag/AgCl reference electrode is 
applied at 400 V/s and a frequency of 10 Hz.  Due to the presence of a large background 
current, electrochemical measurements are background subtracted so oxidative and 
reductive processes of the analyte can be better visualized.  For instance, DA is oxidized 
at +0.6 V and reduced at 0.2 V.  The current measured due to the oxidation and 
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reduction of DA is directly proportional to the concentration of DA found at the site of 
detection.  Thus, FSCV provides a method for the detection of DA release that is 
quantitative and has high temporal and spatial resolution. 
Post-synaptic effects of DA neurotransmission in vivo are studied using 
electrophysiology, namely, extracellular single-unit recordings.  As described in Part I of 
this Chapter, single-unit recordings measure the electrical properties of single neurons 
that are less than ~50 µm from the recording electrode.  Fine metal wires (few microns in 
diameter) encased in glass are normally used as the recording electrode in these 
experiments.  However, carbon-fiber microelectrodes may also be used for single-unit 
recordings.  This approach offers the significant advantage of being able to monitor pre-
synaptic and post-synaptic events in the same experiments.  Additionally, as will be the 
focus of this dissertation, carbon-fiber microelectrodes can also be coupled to 
iontophoretic drug delivery, making this approach even more advantageous. 
Dopamine signaling in the striatum 
DA neuron cell bodies are located in the substantia nigra, ventral tegmental area 
(VTA), and hypothalamus.  From there, these neurons project into several areas of the 
brain, including the prefrontal cortex, hippocampus, and striatum.  Projections traveling 
through the medial forebrain bundle (MFB) innervate the striatum, a DA target involved 
in the processing of reward.  The majority of the cell bodies found in the striatum are 
medium spiny neurons (MSNs), which contain GABA, the principal inhibitory 
neurotransmitter in the CNS.  In addition to DA innervation, MSNs receive strong inputs 
from the cortex and thalamus releasing glutamate, the principal excitatory 
neurotransmitter in the CNS.  Thus, the striatum has been proposed to be a processing 
center responsible for maintaining a smooth flow of signaling.  DA in the striatum 
modulates glutamatergic signaling through dopamine receptors found post-synaptically 
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on MSN dendrites.  However, unlike classical neurotransmission, DA neurotransmission 
is thought to be both synaptic and extrasynaptic.  Morphological and functional evidence 
suggests that DA is a volume transmitter, that is, it diffuses in the extracellular space for 
a distance much larger than the synaptic cleft (Zoli et al., 1998).  This means that DA 
modulation of striatal signaling occurs at a variety of sights post-synaptically.  Electron 
microscopy experiments have revealed that DA acts at four anatomically distinct sites: 
inside the DA synapse, adjacent the DA synapse, inside cortical glutamatergic 
synapses, and at extrasynaptic sites (Schultz, 1998).  A depiction of DA modulation at 
these sights is shown in Figure 1.5. 
Several dopamine receptors have been cloned and are classified into two main 
subtypes: D1-like or D2-like.  The D1 and D5 receptors make up the D1-like receptor 
family and are liked to Gs proteins that activate adenylyl cyclase.  Conversely, D2-like 
receptors inhibit adenylyl cyclase and consist of D2, D3 and D4 receptors.  In the striatum, 
D1 and D2 receptors are found on MSNs, with estimates that ~80% of dopamine 
receptors are D1 and the other 20% are D2  (Schultz, 1998).  Although some reports 
indicate that D1 and D2 receptors may be co-localized on MSNs, evidence suggests that 
the majority of MSNs are anatomically segregated.  The differing projections have lead 
to the classification of “direct” and “indirect” striatonigral pathways. MSNs that project to 
the globus pallidus and substantia nigra express high levels of D1 receptors, and are 
part of the “direct” pathway.  The “indirect” pathway, consisting of neurons that project to 
an external segment of the globus pallidus (which then project to the substantia nigra), 
express high levels of D2 receptors (Nicola et al., 2000).  Perhaps to compensate for 
differences in receptor expression, D1 and D2 receptors exist primarily at different 
affinity states.  Although D1 receptors are the most abundant, they are primarily in a low-
affinity state, and require relatively high concentrations of DA (µM) for activation.  D2  
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Figure 1.5.  Targets of DA signaling in the striatum.  DA terminals in the striatum 
synapse onto the necks of medium spiny neurons, which are GABAergic.  MSNs also 
receive inputs from the cortex in by glutamatergic projections.  DA release in the striatum 
serves to modulate striatal signaling by affecting multiple sites.  Within the DA synapse, 
DA acts on either D1 or D2 receptors.  DA will also diffuse out of the synaptic cleft to 
target adjacent DA targets, and targets within the cortical synapse.  Extra-synaptic DA 
release can modulate signaling by activating D2 receptors found on more distant sites.  
Additionally, cortical inputs that release glutamate will affect DA release, thereby 
modulating striatal signaling. (Figure from ref (Schultz, 1998) ).  
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receptors, on the other hand, are typically in a high affinity state and become activated 
by low concentrations of DA (nM) (Schultz, 1998). 
In addition to being found post-synaptically on MSNs, D2 receptors are found 
presynaptically on DA terminals.  These receptors, termed autoreceptors, serve to 
modulate the release of dopamine.  Activation of D2 autoreceptors triggers a series of 
intracellular events resulting in the inhibition of tyrosine hydrolxylase, the enzyme 
necessary for dopamine synthesis.  It also modulates K+ channels lowering release 
probability.  The net result is a decrease in dopamine release which occurs on a time 
scale of seconds.  Indeed, presynaptic autoinhibition of DA may impact striatal signaling 
by filtering baseline DA signals and only letting through higher frequency signals (Grace, 
2000; Schmitz et al., 2003).  Additionally, experiments in anesthetized rats have shown 
that the duration and range of DA action is directly linked to the activity of the dopamine 
transporter (DAT), which is responsible for reuptake of DA into the presynaptic terminal 
(Garris et al., 1994b).  
Studying the role of DA in the striatum with iontophoresis 
The complex signaling of DA in the striatum has lead many researchers to ask 
what the exact role of DA in the striatum is.  Iontophoresis is uniquely suited for tackling 
this question because it allows for DA to be directly applied to MSNs.  To this end, 
extracellular single-unit recording in anesthetized animals has been coupled to 
iontophoresis of endogenous DA.  Results from these experiments were sometimes 
contradictory, but it is now generally accepted that iontophoretically applied DA inhibits 
MSN firing (White et al., 1995; Hu and White, 1997).  However, since spontaneous firing 
of MSNs in anesthetized rats is generally low, the effects of iontophoretically applied DA 
was also examined on cells activated by iontophoretically applied glutamate or by 
stimulation of the cortical inputs .  These experiments showed similar results to those 
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done without glutamate activation, where the application of DA lead to a general 
decrease in cell firing.  It is important to note, though, that this effect has been reported 
to be dose-dependent, with low amounts of DA actually increasing cell firing, and higher 
doses decreasing firing (Hu and Wang, 1988; Williams and Millar, 1990; Hu and White, 
1997).  These findings support the idea that D1 and D2 receptors differentially modulate 
MSN signaling.  Thus, low affinity D1 receptors may be responsible for inhibition, and 
high affinity D2 receptors may be responsible for activation of striatal signaling.   
Work done in awake rats has generally confirmed results obtained from 
anesthetized rats and suggests that the role of DA in the striatum is to gate incoming 
glutamatergic signaling and control the level of spontaneous MSN firing or “noise” 
(Kiyatkin and Rebec, 1997, 1999a, b).  Hence, DA is thought to act as a low-pass filter, 
effectively increasing the “signal-to-noise” of striatal signaling.  However, recent 
evidence demonstrates that glutamate is co-released with DA from DA terminals, further 
complicating interpretation of the role of DA in the striatum (Stuber et al., ; Chuhma et 
al., 2009).  Indeed, to tease apart the roles of DA and glutamate in the striatum selective 
and localized pharmacology will be needed.  To this end, the use of carbon-fiber 
microelectrodes coupled to iontophoretic barrels offers several advantages over other 
recording and drug delivery techniques.   First, carbon-fiber microelectrodes can be used 
to measure presynaptic DA events as well as post-synaptic changes in cell firing.  
Additionally, quantitative iontophoresis is now possible, thanks to the work presented in 
Chapters 1 and 2 of this dissertation.  The use of this technique has been established in 
anesthetized rats, and has confirmed its utility for selective and local pharmacological 
intervention on pre-synaptic processes.   
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Specific Aim 3 
In order to fully understand the role of DA in the striatum it is necessary to 
examine the system as a whole, including post-synaptic modulation and the resulting 
effects on behavior associated with striatal signaling. The focus of specific aim 3 is the 
transfer of quantitative iontophoresis for use in awake rats trained to perform ICSS.  
Although carbon-fiber microelectrodes coupled to iontophoresis have been previously 
used in behaving animals, these experiments have focused on post-synaptic events and 
have not been quantitative (Kiyatkin and Rebec, 1996, 1997, 1999a, b; Windels and 
Kiyatkin, 2006).  Significant challenges are associated with using carbon-fiber 
iontophoresis probes in behaving rats for DA detection and quantitative iontophoresis.  
While several challenges have already been overcome, others remain, and are 
described in Chapter 4. 
Norepinephrine neurotransmission 
Norepinephrine (NE) belongs to the family of catecholamine neurotransmitters, 
and is synthesized from DA by the enzyme dopamine β-hydroxylase.  It has been 
implicated in a diverse set of behaviors related to attention and arousal, including drug 
addiction.  However, despite early studies suggesting a role for NE in drug addiction, DA 
has received the majority of attention.  NE cell bodies in the brain are mainly located in 
the locus coeruleus (LC) and the lateral tegmental noradrenergic fields.  The LC is 
considered the most important noradrenergic nucleus, and projects to various targets 
including the thalamus, hypothalamus, and cortex.  The bed nucleus of the stria 
terminalis (BNST) is a small nuclei which is part of the extended amygdala and receives 
dense noradrenergic inputs from the LC as well as other noradrenergic nuclei.  The 
BNST also receives DA inputs from the VTA and periaquaductal grey (PAG), and 
purportedly sends glutamatergic signals to the VTA.  Thus, due to its anatomical 
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positioning, the BNST has been proposed to be act as a relay center between regions 
implicated in cognitive processing and those implicated in stress and reward.  
NE terminals express α2-adrenergic presynaptic receptors which act as 
autoreceptors to control release.  They also express the NE uptake transporter (NET) 
which is responsible for recycling released NE back into the terminal.  Post-synaptically, 
α- or β-adrenergic receptors are found. The family of α-adrenergic receptors consists of 
α1 and α2; the β-adrenergic receptor family consists of β1, β2., and β3 .  Unlike D1 and 
D2 receptors, the post-synaptic effects of α- or β-adrenergic receptor activation has not 
been extensively studied.  On the presynaptic side, the field is just beginning to 
understand the physiological mechanism by which NE (or DA) affects neurons in the 
BNST (for review see McElligott and Winder 2009).   
Tools for studying norepinephrine neurotransmission in vivo 
All the techniques described above for studying DA can be used to study NE 
neurotransmission.  Like DA, NE is electroactive, and can be monitored 
voltammetrically.  The electrochemistry of DA and NE are almost identical, and thus the 
signals cannot be qualitatively distinguished.  For studies involving DA in the striatum, 
this is typically not a problem since DA is the predominate neurotransmitter released and 
the area is sufficiently large that exact targeting with microelectrodes can be routinely 
done.  The BNST, however, is a much smaller brain region, spanning just a few hundred 
microns in its smallest dimension, and contains both DA and NE, depending on the 
subnuclei being studied.  To accurately study neurotransmission in this brain region 
precise electrode placement is necessary and pharmacology is needed to confirm the 
identity of the measured signal.  A recent study from the Wightman lab showed that NE 
release from the BNST could be monitored using FSCV and carbon-fiber 
microelectrodes.  
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Specific Aim 4 
The final goal of this dissertation is to use quantitative iontophoresis coupled to 
FSCV to probe the mechanisms underlying NE control in the BNST.  Previous 
experiments have demonstrated that α2-adrenergic receptors control NE release.  
However, it is unknown if these effects are localized to terminal regions in the BNST, or 
if regulation occurs through a systemic effect.  The use of quantitative iontophoresis 
coupled to FSCV provides evidence that control of NE release by α2-adrenergic 
receptors is presynaptic.  The results from these experiments are shown in Chapter 4.  
Additionally, catecholamine content in the BNST is a mixture of DA and NE, making 
specific evaluation of the role of just NE or just DA difficult.  The experiments presented 
in Chapter 4 will highlight the utility of using iontophoresis to quickly determine if the 
measured signal is mostly NE or DA. 
OVERVIEW OF DISSERTATION 
The understanding of neurotransmission has greatly increased due to the 
introduction of technological advancements.  Yet, as our understanding increases it 
becomes apparent that neuronal circuitry is extremely complex, and that further 
advancements are necessary.  The overarching goal of this dissertation is to further the 
functionality of in vivo voltammetric measurements of neurotransmission by coupling the 
measurements to a quantitative, selective, and localized drug delivery tool, 
iontophoresis.  The first aims of this dissertation concern the development, 
characterization, and implementation of quantitative iontophoresis coupled to FSCV.  
The final aims are an attempt to highlight the experimental advantages of using this 
technique, while probing relevant neurotransmission questions that have been 
previously unanswered. 
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Chapter 2 
 
Electroosmotic flow and its contribution to iontophoretic delivery 
INTRODUCTION 
Iontophoresis is a technique in which substances are ejected from a micropipette 
under the influence of an electric field.  It is popular among neuroscientists as it can be 
used for the delivery of specific drugs to highly localized regions of the brain without 
disrupting ongoing behaviors, a likely consequence of administering the drugs 
systemically (Overton and Clark, 1992; Shen et al., 1992; Pierce and Rebec, 1995; 
Kiyatkin and Rebec, 1996, 1997; Kiyatkin et al., 2000; Windels and Kiyatkin, 2006; 
Cheer et al., 2007).  Despite the advantages of this approach, it is difficult to determine 
the amount of drug ejected, and thus the technique is typically considered to be non-
quantitative (Bloom, 1974; Purves, 1980a).  Ejections have been evaluated by 
correlating the potency of a drug (as determined by other preparations) to various 
ejection currents (Clarke et al., 1974).  Although this methodology can produce adequate 
dose-response curves, it assumes that the drug acts with similar potency in the brain of 
an intact animal as in other preparations such as brain slices and cell cultures.  This 
assumption is likely not valid due to the complex chemistry of the brain.   
 During iontophoresis, ejection of charged substances is a consequence of two 
processes: electroosmosis and migration (Curtis, 1964).  As such, the observed rate of 
ejection is governed by the observed linear velocity (vobs) that is defined by 
     epeoobs vvv +=     (2.1) 
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where veo is the velocity of electroosmotic flow and vep is the rate of migration.  Each of 
these velocities is further dependent on the individual mobilities as defined by: 
     EE eoµη
εζ =−=eov     (2.2) 
      Eepepv µ=     (2.3) 
where µep and  µeo  are the mobilities of migration and electroosmosis, respectively, E is 
the applied electric-field, ε is the permittivity, ζ is the zeta-potential formed at the glass 
capillary-solution interface, and η is the solution viscosity.   
The role of electroosmosis on the ejection of species from iontophoretic barrels 
has been controversial.  Early experiments were unable to confirm a major contribution 
of electroosmosis (Krnjevic et al., 1963).  In contrast, Szabadi and co-workers used 
radioactivity measurements to show that the neutral molecule glucose could be ejected 
iontophoretically with an efficiency that was 23% of the ejection of norepinephrine, a 
monovalent cation under their conditions (Bevan et al., 1981).  Furthermore, 
electroosmosis has also been documented during transdermal iontophoresis (Scott et 
al., 1993; Volpato et al., 1995; Bath et al., 2000; Guy et al., 2000).   
When electroosmosis is ignored, ejection is due solely to migration and the 
number of moles (M) ejected is defined as:   
      
zF
iTM n=     (2.4) 
where n is the transport number (a number empirically determined that describes the 
percentage of total current that the compound of interest carries), i is the applied current, 
T is the time, z is the charge, and F is Faraday’s constant (Stone, 1985).  From this 
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relationship, one expects that if the transport number is known, quantitative predictions 
of the amount ejected can be made by controlling the applied current and time.  In 
practice, great variability exists in the amount ejected from barrel to barrel despite using 
the same applied current, time, and solution conditions.  Consequently, a direct 
measurement of the amount ejected is necessary for quantitative analysis, since the 
relationship given in equation (4) is an incomplete description of mass transport during 
iontophoresis. 
Numerous approaches have been used to quantify iontophoresis directly using 
techniques such as fluorescence, radioactivity, and electrochemistry (Krnjevic et al., 
1963; Bradley and Candy, 1970; Clarke et al., 1974; Dionne, 1976; Purves, 1977, 1979; 
Armstrong-James et al., 1980; Kruk et al., 1980; Purves, 1980b; Armstrong-James et al., 
1981; Bevan et al., 1981; Gerhardt and Palmer, 1987; Rice and Nicholson, 1989; Fu and 
Lorden, 1996; Bunin et al., 1998).  For example, ion-selective microelectrodes were 
used to monitor ejections of acetylcholine from nearby iontophoretic pipettes.  This was 
done by measuring changes in potential at the ion-selective electrodes due to the 
introduction of acetylcholine to the bath solution.  The study showed that the rate of 
acetylcholine ejection varied for different iontophoresis barrels, thus requiring calibration 
for each pipette barrel (Dionne, 1976).  Purves did extensive work using a cationic 
fluorescent molecule, quinacrine, which showed similar results.  He also showed that 
release from iontophoretic pipettes is time-dependent and is influenced by “the history of 
the pipette” – meaning it is affected by the retaining current applied previous to ejection 
(Purves, 1977, 1979; Purves, 1980a; Purves, 1980b).  Carbon-fiber microelectrodes 
have been used to effectively monitor the ejection of catecholamines in vitro and in vivo, 
but this technique is limited to electroactive substances (Armstrong-James et al., 1980; 
Kruk et al., 1980; Armstrong-James et al., 1981).   
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 In the present work, we further examined the role of electroosmosis in 
iontophoresis using carbon-fiber microelectrodes to monitor the ejection of electroactive 
compounds as described by Millar et al (Armstrong-James et al., 1980; Kruk et al., 1980; 
Armstrong-James et al., 1981).  By using neutral and charged compounds with distinct 
electrochemical signals we monitored the rate of ejection for each separately.  This 
approach allowed us to determine the relative contribution of electroosmosis to the 
ejection of various charged compounds.  Our findings indicate that electroosmosis plays 
a significant role, accounting for over 30% of the total ejection observed for cationic 
compounds and 80% for anionic compounds.  For each compound tested, the rate of 
electroosmotic flow (EOF) relative to the observed ejection remained constant, 
suggesting that the variability in the absolute amount ejected from different pipette 
barrels is due to changes in the amount of EOF present.  Furthermore, differences in 
iontophoretic mobility were correlated with differences in electrophoretic mobility, as 
determined by capillary electrophoresis. 
MATERIALS AND METHODS 
Chemicals.  
Unless noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO) 
and used as received. Solutions were prepared using doubly distilled deionized water 
(Megapure system, Corning, NY).  A physiological buffer solution, pH 7.4, (15 mM TRIS, 
126 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 2.4 mM CaCl2, 1.2 mM NaH2PO4, 1.2 mM 
MgCl2, 2.0 mM Na2SO4) was used in all electrochemical experiments.  
Iontophoresis Probes.  
Multi-barrel (3 or 5) probes were constructed by fusing a single-barrel glass 
capillary (A-M Systems, Carlsborg, WA) to a multi-barrel (2 or 4) glass capillary that 
37 
contain filaments that aid in filling the barrel by capillary action (A-M Systems, Carlsborg, 
WA and Stoelting Co., Wood Dale IL).  The single barrel was loaded with a carbon fiber 
(T-650, Thornel, Amoco Corp., Greenville, SC).  The capillaries were bundled together 
with heat shrink and were tapered to a tip of about 1 µm in diameter using a micropipette 
puller (Narashige, Tokyo, Japan) with a two-step twist and pull process. The protruding 
carbon fiber was cut to a length between 30 and 50 µm.  Before use, barrels containing 
the carbon fiber were backfilled with electrolyte (4 M potassium acetate, 150 mM 
potassium chloride) and fitted with wires for electrical contact.  A silver/silver chloride 
electrode served as the reference. Empty barrels for iontophoresis were filled with 
analyte solutions prepared in 5 mM NaCl at pH 5.8.  An electron micrograph and 
drawing of the assembly with 2 and 4 iontophoretic barrels is shown in Figure 2.1. 
Data Acquisition.  
Cyclic voltammograms were acquired using data-acquisition hardware and local 
software written in LabVIEW (National Instruments, Austin, TX). The cyclic voltammetry 
waveform was generated and the voltammetric signal was acquired with an A/D, D/A 
board, the PCI-6052E (National Instruments). A PCI-6711E D/A board (National 
Instruments) was used to synchronize waveform application, data acquisition, and to 
trigger the iontophoretic current applied and the loop injector in the flow injection 
apparatus. The voltammetric waveform was input into a custom-built instrument for 
application to the electrochemical cell and current transduction (University of North 
Carolina at Chapel Hill, Department of Chemistry Electronics Facility).  After collection,  
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background subtraction, signal averaging, and digital filtering (low pass filtered at 1 kHz) 
were all done under software control.  
For most experiments, a triangular waveform was applied with a scan rate of 200 
V s-1 with a rest potential of -0.7 V versus Ag/AgCl between scans, an initial scan to -1.3 
V, followed by an excursion to 1.0 V, and a scan to the rest potential.  The scans were 
repeated every 100 ms. These parameters were chosen to maximize separation of 
peaks for the analytes being studied. 
Iontophoresis Ejections.   
Multi-barrel iontophoresis probes with a carbon-fiber microelectrode (Figure 2.1) 
were used to eject and detect the analytes that were made up as 10-12 mM solutions in 
5 mM NaCl at pH 5.8 unless otherwise noted.  Positive currents (average of 5 to 40 nA) 
delivered by a constant current source designed for iontophoresis experiments 
(Neurophore, Harvard Apparatus, Holliston, MA) were used to eject the various analytes.  
For each barrel, an appropriate ejection current was determined by first performing 30 
second test ejections until a signal sufficient for analysis was measured (average of -5 to 
-30 nA at the reduction potential of NPE).   In some of the experiments, a retaining 
current of -5 nA was applied between ejections.  For all remaining experiments, a current 
of 0 nA was applied between ejections.   
Flow Injection Apparatus.  
The electrode was positioned at the outlet of a six-port rotary valve37.  A loop 
injector was mounted on an actuator (Rheodyne model 7010 valve and 5701 actuator) 
that was used with a 12-V DC solenoid valve kit (Rheodyne, Rohnert Park, CA) to 
introduce the analyte to the surface of the electrode. The linear flow velocity (1.0 cm s-1) 
40 
was controlled with a syringe infusion pump (Harvard Apparatus model 940, Holliston, 
MA).  
Special considerations were necessary because oxygen can be detected with the 
waveform used.  Therefore, PEEK® tubing (Upchurch Scientific, Oak Harbor, WA) and 
glass syringes were used to limit oxygen interference, and all solutions were degassed 
with nitrogen before use. 
HPLC Experiments.   
Iontophoretic ejections were made into a 500 µL volume of 0.1 N perchloric acid.  
HPLC injections (10 µL) were made onto a reverse phase column (C-18, 5 µm, 4.8 x 250 
mm, Waters symmetry 300).  The mobile phase (prepared in HPLC grade water) 
contained 0.1 M citric acid, 0.1 mM EDTA, and 1 mM hexyl sodium sulfate, pH 3.5 and 
10% organic modifier (methanol).  Analytes were detected with a thin-layer radial 
electrochemical flow cell (BASi, West Lafayette, IN USA), with the working electrode at 
0.7 V vs. the Ag/AgCl reference.  Data was collected using a custom written LabVIEW 
program (Courtesy of Professor James Jorgensen, UNC-CH).  Peak areas were 
calculated using statistical moments regression (Igor Version 5.0).  Differences in 
detection efficiency were normalized for by using a response ratio for each analyte.   
Capillary Electrophoresis Experiments.   
These were performed using a HP3DCE system (Agilent Technologies) equipped 
with an on-column diode-array detector, an auto-sampler and a 30 kV power supply. CE 
Chemstation (Agilent Technologies) was used for CE control, data acquisition and 
handling. The separation was performed in a 50 µm fused silica capillary 96.0 cm in total 
length, and 87.5 cm to the UV detector. All experiments were carried out in cationic 
mode (the anode at the inlet and cathode at the outlet).  Samples were run at a 
41 
concentration of 2 mM in 17 mM PBS (phosphate buffered saline, made up of 0.25% 
monosodium phosphate and 0.04% disodium phosphate) with a pH of 5.8 to keep 
constant with the buffer conditions used for the iontophoresis experiments.  UV detection 
was measured at 195 and 240 nm.  The electrophoretic mobility was calculated as: 
⎟⎠
⎞⎜⎝
⎛⎟⎟⎠
⎞
⎜⎜⎝
⎛=
V
L
t
L t
r
epµ      (5) 
where L is the distance from the inlet to the detection point, tr is the time required for the 
analyte to reach the detection point, V is the applied voltage, and Lt is the total length of 
the capillary (Skoog et al., 2007). 
RESULTS AND DISCUSSION 
Construction of carbon-fiber iontophoresis probes. 
Initially, probes were constructed using only multi-barrel glass by loading one 
barrel with a carbon fiber and then pulling the assembly to a fine tip.  Although this 
approach provided adequate results, it had two disadvantages.  First, multi-barrel glass 
comes either with or without filaments.  The filaments are needed for backfilling solutions 
into the barrels for iontophoresis.  However, when the carbon fiber is placed in one of 
these filament-containing barrels, it can reduce the quality of the carbon fiber- glass seal 
which will increase the magnitude of the cyclic voltammetric background current.  
Second, some of these probes exhibited electrical cross-talk between the iontophoresis 
barrels and the barrel containing the carbon-fiber.  We believe this is due to the thin 
glass that separates the barrels, which when filled with ionic solutions, allows capacitive 
coupling.   
To remedy these problems, we modified our construction techniques by using 
multi-barrel, filament glass for iontophoresis, and then fusing a separate single barrel 
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capillary to it (without a filament) for electrochemical detection.  This improved the 
carbon-fiber glass seal and electrical crosstalk was much less likely to be seen.  This 
procedure allows fabrication of any number of configurations using 2, 3, and 4-barrel 
glass, and we have seen no difference in performance.  Images of a 2 and 4-barrel 
capillary fused to single capillary containing a carbon-fiber microelectrode are shown in 
Figure 2.1. 
Quantitative iontophoresis of electroactive compounds.   
We were able to monitor iontophoretic ejections in real-time by coupling 
iontophoresis with fast-scan cyclic voltammetry (Figure 2.1).  Figure 2.2 shows 
consecutive ejections of 10 mM dopamine with an applied iontophoretic current of 10 nA 
and a retaining current of -5 nA.  The ejections are fairly reproducible and show fast time 
responses.  As seen from the cyclic voltammogram, the expected signature peak from 
the oxidation of dopamine occurs at around 0.6 V.  After calibration, the oxidation current 
was converted to dopamine concentration, which shows that for 10 nA of iontophoretic 
current, the signal at the carbon-fiber surface is equivalent to that found in a 5 µM 
dopamine solution.  In reality, the concentration along the electrode length varies with 
the concentration (10 mM) of dopamine within the barrel at the micropipette tip, to 
progressively lower concentrations down the length of the cylindrical electrode.  This 
concentration profile approximates the dilution expected for ejection from a point source 
(Nicholson et al., 1979). 
To characterize the role of electroosmosis in iontophoretic ejections, we chose a 
neutral, electroactive compound to serve as a marker for EOF. Considerations such as 
pKa, solubility in water, and lack of voltammetric overlap with dopamine limited the  
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Figure 2.2. Analysis of consecutive iontophoretic ejections of dopamine.  Carbon-fiber 
iontophoresis probes were used to eject a solution of dopamine cations at pH 5.8 into a 
solution of TRIS buffer at pH 7.4.  Upper left:  Solid line represents the concentration of 
dopamine measured at its oxidation potential of 0.6 V vs. time trace obtained for three 
consecutive 10 nA ejections at times indicated by the horizontal bars.  Lower left: Color 
representation of the iontophoretic ejections shown, with applied voltage at the carbon 
fiber plotted vs. time and the current measured in response to dopamine ejection plotted 
in false color.  Right: Cyclic voltammogram obtained at the time indicated by the white 
dashed line in the color plot. 
 
  
2 µM DA
2 µM DA
10 nA
‐7 nA
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options available.  The pKa determines whether the molecule is neutral at the pH values 
used during experimentation.  Solubility in water is essential because it is the preferred 
solvent for making up drug solutions typically used in iontophoresis; other solvents can 
affect EOF and may also be toxic when used in biological experiments.  The EOF 
marker must be voltammetrically different from dopamine so that the signals from each 
can be resolved.  With all of these prerequisites in mind, we chose 2-(4-nitrophenoxy) 
ethanol as the EOF marker for the experiments performed with FSCV (Figure 2.3). 
Figure 2.4 illustrates iontophoretic ejections of a mixture of dopamine and NPE at 
equal concentrations (10 mM).  The pH of this solution is 5.8, at which NPE is neutral 
and dopamine is a monocation.  Ejection of both of these compounds confirms that EOF 
plays a role in iontophoresis since the only mechanism for ejection of NPE is 
electroosmosis.  Much like the results for dopamine, ejections of NPE are reproducible 
and rapid.  As seen from the cyclic voltammogram, the oxidation of dopamine can be 
seen at around 0.6 V, whereas the reduction of NPE can be seen at about -1.2 V, 
facilitating the quantification of both species.  Because dopamine is charged, its ejection 
should be due to iontophoretic forces and electroosmosis; consistent with this 
expectation more dopamine (~14 µM) than NPE (~6 µM) is detected at the electrode 
surface. 
Variability in iontophoresis. 
Although ejections are reproducible for a given barrel (demonstrated in Figures 
2.2, 2.3, and 2.4), there is substantial variability when ejections from various barrels are 
compared to one another for a given iontophoretic current.  The top panel of Figure 2.5 
shows NPE ejections from 5 different iontophoretic barrels containing the same solution 
(10 mM NPE).  The apparent concentration recorded with the cylindrical electrode is  
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Figure 2.3. Analysis of consecutive iontophoretic ejections of a neutral marker 
compound, NPE.  Carbon-fiber iontophoresis probes were used to eject a solution of 
NPE at pH 5.8 into a solution of TRIS buffer at pH 7.4.  Upper left:  The solid line 
represents [NPE] at -1.2 V (light blue solid line) measured vs. time trace obtained for 
three consecutive 10 nA ejections at times indicated by the horizontal bars.  Lower left: 
Color representation of the iontophoretic ejections shown, with applied voltage at the 
carbon fiber plotted vs. time and the current measured in response to NPE ejection 
plotted in false color.  Right: Cyclic voltammogram obtained at the time indicated by the 
white dashed line in the color plot.  
 
5 µM NPE
10 nA
‐7 nA
5 µM NPE
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Figure 2.4. Analysis of consecutive iontophoretic ejections of dopamine and NPE.  
Carbon-fiber iontophoresis probes were used to eject a mixture of dopamine and NPE at 
pH 5.8 into a solution of TRIS buffer at pH 7.4.  Upper left:  The solid lines represent 
[DA] at 0.6 V (black) and [NPE] at -1.2 V (light blue) measured vs. time trace obtained 
for three consecutive 10 nA ejections at times indicated by the horizontal bars.  Lower 
left: Color representation of the iontophoretic ejections shown, with applied voltage at the 
carbon fiber plotted vs. time and the current measured in response to dopamine and 
NPE ejection plotted in false color.  Right: Cyclic voltammogram obtained at the time 
indicated by the white dashed line in the color plot.   
10 µM DA
5 µM NPE
10 nA 10 nA10 nA
10 µM DA
20 nA
‐13 nA
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linear with ejection current.  The difference in the slope of the 5 lines indicates that each 
barrel is ejecting at a different rate.   
Previous experiments by Bradley and Candy compared the amount of ejected 
cations for large and small diameter pipette tips (Bradley and Candy, 1970).  Their 
results showed that the larger diameter pipettes ejected more for a fixed ejection current 
than small diameter pipettes.  To examine whether this is the cause of variability in our 
experiments, the tip diameter of the iontophoretic barrels used was estimated from 
scanning electron microscope (SEM) images of the probes that were employed.  One of 
the barrels contained a carbon fiber, while one of the other barrels was used to eject 
either dopamine or NPE.  The concentration of dopamine or NPE detected during 
ejection followed similar behavior, and showed a correlation with the diameter of the 
ejection tip (Figure 2.5).  Since the ejection of both neutral and charged species depends 
on the electric field (E) at the tip (equations 2 and 3), the variation likely arises because 
E is a function of the tip geometry.  However, because we have not characterized the 
collection of ejected amounts with different dimensions of the iontophoretic barrel, a 
quantitative interpretation cannot be made.  Even so, it is clear that the variability in tip 
dimensions leads to variability of the ejected amounts.   
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Figure 2.5. Variability of iontophoretic ejections for different barrels.  Upper:  5 different 
probes were used to eject a mixture of dopamine and NPE at currents ranging from 1 -
10 nA into TRIS buffer.  Each line represents the linear dependence of applied current to 
the amount of NPE ejected, as well as the difference in ejection efficiency for each 
barrel.  (Dopamine showed an identical relationship, although not shown here). Lower:  
Different probes were used to eject dopamine or NPE into TRIS buffer using a 10 nA 
ejection current.  After the ejections, SEM images of the probes were obtained to 
estimate the tip diameter of the iontophoresis probes.  Plotted is the relationship 
between the amount of NPE (solid squares) and dopamine (empty diamonds) ejected at 
10 nA and the diameter of tip. 
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Quantification of electroosmosis and migration.  
The concentrations measured at the electrode surface are directly related to the 
flux at the iontophoretic tip and indicate the individual contributions from iontophoresis 
and electroosmosis.  The pH of the solution in the barrel is critical because it will 
determine the charge of the compound in solution and the extent to which the silanol 
surface groups on the glass capillaries are ionized.  To demonstrate the importance of 
the latter, the relative iontophoretic delivery of dopamine, a cation at pH values below pH 
~7.4, and NPE, a marker for EOF, were compared from solutions of pH 5.8 and 4.0.  
Decreasing the pH increases protonation of the silanol groups and should decrease the 
ζ potential, thus decreasing the contribution of EOF.  Consistent with this, the relative 
amount of dopamine ejected was greater at pH 4.0 due to the decreased transport of 
NPE by EOF.   
To characterize the role of electroosmosis for other molecules, NPE was used as 
the marker for EOF at pH 5.8, and it was paired with a set of neutral and charged 
molecules that exhibit electrochemistry similar to that of dopamine shown in Figures 2.2 
and 2-4.  Acetaminophen (AP) and hydroquinone (HQ), which are both neutral at pH 5.8, 
traveled at the same speed as the EOF marker, NPE.  As expected, charged molecules 
uric acid, norepinephrine, and dopamine, moved at rates that were significantly different 
from EOF.  It might seem surprising that uric acid, an anion at the pH used, can be 
ejected with a positive current.  This arises because electroosmosis effectively competes 
with the iontophoretic mobility that carries uric acid in the opposite direction.  
Norepinephrine and dopamine, which are cations, have transport rates that are 
enhanced by their respective iontophoretic mobilities.  Importantly, over a series of at 
least 5 barrels, the ratio between each compound tested and NPE remained reasonably 
constant as indicated by the standard deviations.  That is, the fraction of the observed 
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ejection due to EOF did not vary, despite fluctuations in the absolute amount of 
compounds ejected.  Thus, consistent with the results in Figure 2.5(B), variations in EOF 
arising from differences in the tip diameter are the origin of the variability in the amounts 
ejected of both neutral and charged compounds.  
Carbon-fiber iontophoresis probes were used to deliver a mixture consisting of a 
charged compound (10 mM) and the EOF marker, NPE (10 mM), into 1X TRIS buffer 
(pH 7.4).  The values given are the average of at least 6 different barrels for each of the 
compounds tested.  For each barrel, 25 consecutive ejections were averaged at ejection 
currents ranging from 1 nA to 100 nA as needed to deliver concentrations of NPE in the 
5-50 µM range. 
The differences in mobility observed in our iontophoresis experiments match 
differences in electrophoretic mobilities observed in published data (Wallingford and 
Ewing, 1987) and are confirmed by our own experiments as demonstrated in Figure 2.6.  
As such, it is possible to use electrophoretic mobility data in conjunction with 
iontophoresis data to make predictions of the rate of transport relative to EOF for 
compounds that are not electroactive, but that can be detected in the UV.  Such 
compounds include quinpirole and raclopride, both of which are important drugs 
frequently studied in our laboratory.  Such an approach has been used to characterize 
transdermal iontophoresis and the zeta potential of brain slices in rats (Abla et al., 2005; 
Guy et al., 2008).  Although our experiments were run in the presence of 5 mM NaCl, 
electroosmosis is still an effective transport mechanism with much higher ionic strength.   
Since iontophoretic ejections generate high, localized concentrations of analyte 
near the point of ejection, there was concern that quantitative measurements of the 
amount ejected may be convoluted due to differences in electrode response along its  
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Table 2.1.  Rate of iontophoretic delivery of charged compounds relative to EOF as 
measured by FSCV. 
Compound Ejected by Iontophoresis  Concentration Ejected Relative to NPE  
Dopamine (pH 4.0) 3.56 ± 0.27 
Dopamine (pH 5.8) 2.57 ± 0.30  
Norepinephrine (pH 5.8) 2.04 ± 0.27  
Hydroquinone (HQ) (pH 5.8) 1.01 ± 0.02  
Acetaminophen (AP) (pH 5.8) 0.95 ± 0.06 
Uric Acid (pH 5.8) 0.49 ± 0.18 
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length.  To ensure that this would not present a problem, we used HPLC as an 
independent measure to confirm the results obtained with our carbon-fiber iontophoresis 
probes.  With HPLC we can separate a mixture post-ejection, and quantitatively 
determine how much was ejected by oxidizing at +0.7 V vs. Ag/AgCl.  For these 
experiments, 10 minute iontophoretic ejections of AP and HQ were made into a known 
volume of perchloric acid (500 µL).  Analysis of the mixture showed that the rate of 
transport for HQ relative to AP was 1.04 ± 0.21.  This result is expected for two neutrals, 
and is in agreement with those obtained with the carbon-fiber iontophoresis probe 
measurements using NPE.    
Effects of retaining currents. 
 Traditionally, a retaining current is applied between ejections during 
iontophoresis to control for diffusive leakage.  Given the tip size of our iontophoresis 
probes, we hypothesized that retaining current may not be necessary.  To test this, we 
performed a series of dopamine ejections at various retaining currents.  Initially the 
barrel was held at -10 nA for 6 minutes, and then the current was progressively 
increased to more positive currents and held at that current for another 6 minutes.  
During each of these ejection currents, the amount of dopamine and NPE ejected was 
monitored.  If the electrodes were leaking between ejections, it is predicted that some 
ejection would be seen when the current was changed from -10 nA to -5 nA to -2 nA to 0 
nA, since at each transition there would be less retaining current to control for leakage.  
As seen in Figure 2.7 this was not the case.  In each of those transitions, no ejection 
was observed.  Ejection was only observed when the current switched from 0 nA to 3 
nA, indicating that no retention current is necessary, and holding at 0 nA is sufficient. 
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Figure 2.7.  Effects of retention current on iontophoretic ejections.  Carbon-fiber 
iontophoresis probes were used to ejected dopamine cations after the application of 
retaining currents ranging from -10 nA to 0 nA.  Each retaining current was applied for 6 
minutes prior to the application of a higher ejection current for 6 minutes.  The solid lines 
(amplified in the inset) represent the amount of dopamine ejected after the application of 
-10 nA retaining current followed by -5 nA (dark gray) ejection current, -5 nA retaining 
current followed by -3 nA ejection current (gray),  and -3 nA retaining current followed by 
0 nA (light gray). The black solid line shows the amount of dopamine ejected after 
holding the barrel at 0 nA for 6 minutes and then applying +3 nA for ejection current.  
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Considerations for in vivo use. 
 Carbon-fiber microelectrodes have been routinely used to study fluctuations of 
catecholamines in the brain of anesthetized and freely-moving rats (Robinson et al., 
2008).  Carbon-fiber iontophoresis probes have also been used to deliver drugs to 
localized regions, and subsequently detect the changes induced in catecholamine 
release with electrochemistry1.  However, quantitation of the amounts ejected has 
remained a challenge, except in the rare cases when the drugs used are electroactive.  
Since electroosmosis seems to be the transport mechanism most affected by the 
variations present from barrel to barrel, it makes sense to use a marker for EOF as an 
indicator of the variability present.  In addition, because the relationship between EOF 
and migration of charged compounds remains constant, the marker for EOF can be used 
as an internal standard to calibrate for the amounts of non-electroactive drugs ejected. 
 This methodology can be readily used in vivo with any electroactive neutral 
molecule, such as NPE, acetaminophen, or hydroquinone.  It is important to keep in 
mind that the electrochemistry of some of these compounds may overlap with that of 
catecholamines. As such, if the experiment requires continuous ejection and detection of 
released cathecholamines, it would be advantageous to use NPE which does not 
overlap.  Toxicity remains a concern, although given the localized nature of iontophoretic 
ejections and the effects of dilution, it is expected that this is minimal. 
CONCLUSIONS. 
 A long-standing disadvantage of iontophoresis has been its non-quantitative 
nature.  Using carbon-fiber iontophoresis probes we have shown that the main challenge 
with quantitating iontophoretic ejections is the variability observed from barrel to barrel 
due to varied tip dimensions which affects electroosmosis.  Using NPE, AP, or HQ as 
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neutral markers for EOF, it is now possible to quantitate this variability.  In addition, the 
positive correlation observed between electrophoretic mobility and iontophoretic mobility 
relative to our EOF markers enables us to extend this methodology and make 
quantitative predictions for compounds that are not electroactive, but that can be 
measured by other detection schemes used with CE such as UV or fluorescence.  We 
plan to use this approach for quantitative iontophoresis applications in the study of 
neurotransmitter release and modulation in the brain of anesthetized and freely-moving 
rats. 
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Chapter 3 
Probing pre-synaptic regulation of dopamine release with iontophoresis 
INTRODUCTION 
Iontophoresis was first developed by W.L. Nastuk, a student of A.L. Hodgkin, 
who was interested in how the actions of acetylcholine (ACh) on the neuromuscular 
junction were altered with changes in the ionic composition of the extracellular bath 
solution (Hicks, 1984).  His previous studies with intracellular pipette recordings led him 
to the discovery that if pipettes were pulled to a coarse tip and then filled with ACh, some 
would slowly diffuse out.  He expanded on this observation and decided to electrically 
control delivery of ACh through the glass pipettes, and thus iontophoresis was born in 
1953 (Nastuk, 1953).  Recognizing that fast and controlled delivery of ACh could be 
used to search and map end-plate regions on the neuromuscular region, many 
researchers, including del Castillo and Katz, used it to study the actions of ACh on 
synaptic sites (Del Castillo and Katz, 1955, 1956; Axelsson and Thesleff, 1959; Miledi, 
1960).  The first studies using iontophoresis in the central nervous system were made by 
Eccles and Curtis who were interested in studying Renshaw cells and used the first 
account of a multi-barrel iontophoresis probe to locate and modulate cells (Curtis and 
Eccles, 1958; Curtis et al., 1960; Curtis and Koizumi, 1961).   
Throughout the remainder of the 1950s and into the 1970s, iontophoresis grew in 
popularity, and important contributions concerning the advantages and disadvantages of 
iontophoretic drug delivery were made (Krnjevic et al., 1963a; Krnjevic et al., 1963b; 
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Crawford and Curtis, 1964; Curtis and Nastuk, 1964; Bradley and Candy, 1970; Bloom, 
1974; Simmonds, 1974; Freedman et al., 1975; Purves, 1977, 1979).  The technique 
was (and is) favored for studying receptor dynamics in vivo because drugs can be 
quickly, selectively, and locally delivered to the site (or sites) of action.  Traditional 
methods of pharmacological intervention such as intraperitoneal or intravenous delivery 
affect the entire brain and can confound interpretation of the measured results.  
Furthermore, only drugs that can pass the blood-brain barrier can be used for system 
drug delivery, and even then, metabolism of the drug may reduce its effects (Bloom, 
1974).  Iontophoresis circumvents all of these problems, making it very attractive for 
pharmacological neurobiology studies. 
However, despite the clear advantages of iontophoresis, challenges with 
reproducibility and quantitation of drug delivery have prevented the technique from being 
more widely used (Del Castillo and Katz, 1955; Krnjevic et al., 1963b; Curtis and Nastuk, 
1964; Bloom, 1974; Purves, 1977, 1979; Purves, 1980a; Purves, 1980b; Armstrong-
James et al., 1981; Stone, 1985).  A major drawback of iontophoresis as it has been 
previously used is that there is no way to differentiate between an unresponsive site and 
a faulty drug ejection.  Recently, we modified the design of Millar and co-workers, 
coupling iontophoresis barrels to carbon-fiber microelectrodes to allow the 
concentrations of electroactive compounds delivered by iontophoresis to be monitored 
with fast-scan cyclic voltammetry (Armstrong-James et al., 1981).  While characterizing 
iontophoretic delivery, we found that electroosmosis contributes significantly to the 
observed drug delivery.  Electroosmosis is due to ionizable silanol groups on the glass 
capillary surface which attract cations in solution to form an electrical double layer.  
When a positive current is applied to the capillary, the cations along the wall migrate 
toward the anode (outside of the capillary), creating a bulk movement of solution, termed 
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electroosmotic flow (EOF).  Thus, iontophoretic delivery is governed by the traditional 
mechanism attributed to iontophoresis, ion migration, and EOF.  In addition, we showed 
that an electroactive neutral molecule could serve as an internal standard to monitor the 
variability in the amount of drug delivered from different barrels.  These insights into the 
iontophoresis technique enable quantitative delivery of electroactive and electroinactive 
drugs by monitoring the ejection of an electroactive EOF marker (Herr et al., 2008).   
Although fast-scan cyclic voltammetry has been previously combined with 
iontophoresis for neurophysiology experiments, it has not been used to modulate pre-
synaptic release of neurotransmitters (Kiyatkin and Rebec, 1996, 1997; Rebec, 1998; 
Kiyatkin and Rebec, 1999b, a; Kiyatkin et al., 2000; Kiyatkin and Rebec, 2000).  In this 
chapter, the use of quantitative iontophoresis for the modulation of dopamine release in 
the striatum of anesthetized rats is demonstrated.  Ejections are characterized in vivo 
with particular emphasis on leakage and the time course of drug ejection.  In addition, 
the effects on dopamine release upon application of two electroactive marker molecules, 
AP and 2-(4-nitrophenoxy) ethanol (NPE) are tested to ensure that our method of 
quantitation does not alter the biological system.  Expanding on previous work, he 
relative mobilities of drugs of pharmacological interest that are not electroactive are 
quantified.   Finally, it is demonstrated that dopamine neurotransmission can be locally 
modulated at terminals by affecting D2 autoreceptors and the dopamine transporter.   
MATERIALS AND METHODS 
Chemicals.  
Unless noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO) 
and used as received. Chemical structures of the species used are shown in Figure 3.5.  
Solutions were prepared using deionized water.  A physiological buffer solution, pH 7.4, 
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(15 mM TRIS, 126 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 2.4 mM CaCl2, 1.2 mM 
NaH2PO4, 1.2 mM MgCl2, 2.0 mM Na2SO4) was used in all calibration experiments.   
Animals and surgery.   
Male Sprague-Dawley rats (225-350g; Charles River, Wilmington, MA) were 
anesthetized with urethane (1.5 g/kg, i.p.) and placed in a stereotaxic frame (Kopf, 
Tujunga, CA).  Holes were drilled in the skull on the right hemisphere for the working and 
stimulating electrodes at coordinates selected from the atlas of Paxinos and Watson 
(Paxinos and Watson, 2005).  An Ag/AgCl reference electrode was inserted in the left 
hemisphere.  The carbon-fiber iontophoresis probe was placed in the striatum (AP +1.2 
mm, ML +2.0 mm, and DV -4.5 to -6 mm).  The stimulating electrode was placed in the 
medial forebrain bundle (AP -2.8mm, ML +1.7 mm, and DV -8.5mm).  The carbon-fiber 
and stimulating electrodes were individually adjusted in the dorsal-ventral coordinate to 
locate the optimal locations for stimulated dopamine release.   
Electrical Stimulation.  
 An untwisted bipolar stimulating electrode (Plastics One, Roanoke, VA) was used to 
stimulate dopaminergic neurons using a pair of linear constant current stimulus isolators 
(model NL80A, NeuroLog System, Digitimer Ltd, UK).  The stimulation train consisted of 
40 biphasic pulses (± 300 µA, 2 ms/phase unless otherwise noted) applied at 60 Hz.  
The pulses were generated by a computer and applied between the cyclic 
voltammograms to avoid electrical interference.   
Iontophoresis Probes.   
A glass capillary (Part # 624503, 0.60 mm o.d., 0.4 mm i.d., 4” long, A-M Systems, 
Sequim, WA) was loaded with a carbon fiber (T-650, Thornel, Amoco Corp., Greenville, 
SC) that served as the working electrode.  This capillary containing the carbon fiber was 
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then inserted into one barrel of a 4-barrel capillary (Part # 50644, 1 mm o.d., 0.75 mm 
i.d., 4barrel GF pipettes, 4” long, Stoelting Co., Wood Dale IL).  The four barrel assembly 
contained glass filaments (GF) in each barrel that aid in filling the barrel by capillary 
action.  The capillaries were bundled together with heat shrink and tapered to a sharp tip 
using a micropipette puller (Narashige, Tokyo, Japan) with a two-step pull process.  The 
protruding carbon fiber was cut to a length between 30 and 50 µm by careful use of a 
scalpel under a 10X microscope objective.  The resulting probe consists of a glass-
encased carbon fiber that is 5-7 µm in diameter and 3 iontophoretic barrels each about 1 
µm in diameter.  Before use, the barrel containing the carbon fiber was backfilled with 
electrolyte (4 M potassium acetate, 150 mM potassium chloride) and fitted with wires for 
electrical contact.  The remaining barrels for iontophoresis were filled with solutions 
containing reagents to be ejected.   
Electrochemical Data Acquisition and Presentation.   
Cyclic voltammograms were acquired using data-acquisition hardware and 
locally software written in LabVIEW (National Instruments, Austin, TX). The cyclic 
voltammetry waveform was generated and the voltammetric signal was acquired with a 
computer interface board, the PCI-6052E (National Instruments). A PCI-6711E D/A 
board (National Instruments) was used to synchronize waveform application, data 
acquisition, and to trigger the iontophoretic current applied and the loop injector in the 
flow injection apparatus. The voltammetric waveform was input into a custom-built 
instrument for application to the electrochemical cell and current transduction (University 
of North Carolina at Chapel Hill, Department of Chemistry Electronics Facility).  After 
data collection, background subtraction, signal averaging, and digital filtering (low pass 
filtered at 2 kHz) were all done under software control.  
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For all experiments, a triangular waveform was applied with a scan rate of 400 V 
s-1 with a rest potential of -0.4 V versus a Ag/AgCl reference electrode between scans, a 
linear scan to 1.3 V, followed by a scan back to the rest potential.  The scans were 
repeated every 100 ms, and collection was typically for 15- 60 s.  This large amount of 
data is presented as a color plot, with the applied voltage plotted on the ordinate, time on 
abscissa, and measured current in false color. 
Iontophoresis Ejections.   
Characterizations studies involving the effects of the neutral marker molecule on 
stimulated dopamine release were done with solutions made up at 10 mM 
concentrations of acetaminophen, 2-4(nitrophenoxy) ethanol, in 5 mM NaCl.  The effects 
of saline were studied with 5 mM NaCl solutions.  For studies involving the modulation of 
stimulated dopamine release, each barrel of the iontophoresis assembly was filled with 
either raclopride tratrate salt, nomifensine maleate salt, or quinpirole hydrochloride and 
the EOF marker, usually AP, at concentrations of ~10 mM each, in 5 mM NaCl at pH 5.8.  
These concentrations of drug and supporting electrolyte were chosen for the following 
reasons: for the following reasons.    Electrolyte is needed to facilitate conductivity and to 
ensure adequate and reproducible EOF without it being so high that EOF is suppressed 
(Cazes, 2001).  Therefore 5 mM NaCl was chosen as a compromise between the two 
limits.  Traditionally, drug concentrations are higher than used here and barrels are 
sometimes loaded with drugs at concentrations of 250 mM. However, given that we are 
able to electrochemically monitor drug ejection, we determined that 10 mM is sufficiently 
concentrated to get observable ejection, and observe effects on stimulated dopamine 
release.  Ejection currents were delivered by a constant current source designed for 
iontophoresis (Neurophore, Harvard Apparatus, Holliston, MA).  For each barrel, an 
ejection current (between 5 to 40 nA) was selected by evaluating ejections (30 s 
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duration) that gave a measurable voltammetric signal for the EOF marker (average peak 
current of 5 to 30 nA at the peak potential in the voltammogram).   A current of 0 nA was 
applied between ejections.   
To minimize electrical cross-talk between the electrochemical and iontophoretic 
electrodes, both systems had a common ground.  The reference electrode served as the 
return for the iontophoresis currents and was tied to ground.   The potential of the 
working electrode was controlled by applying the voltage to the non-inverting input of the 
current transducer.   
Calibrations.  
The response of the carbon fiber electrode in the iontophoresis probe was 
calibrated in a flow injection analysis system after in vivo use (Kristensen et al., 1986).  
The probe was positioned at the outlet of a six-port rotary valve.  A loop injector was 
mounted on an actuator (Rheodyne model 7010 valve and 5701 actuator) that was used 
with a 12-V DC solenoid valve kit (Rheodyne, Rohnert Park, CA) to introduce the analyte 
to the surface of the electrode. The linear flow velocity (1.0 cm s-1) was controlled with a 
syringe infusion pump (Harvard Apparatus model 940, Holliston, MA).  The voltammetric 
current was measured at the peak potential for each analyte that was evaluated at 4 
concentrations.   
Capillary Electrophoresis Experiments.  
A home-built CE system equipped with an absorbance detector and a 30 kV 
power supply was employed.  Absorbance traces were collected using a custom written 
LabVIEW program (Courtesy of Professor James Jorgensen, UNC-CH).  Separations 
were carried out in a 50 µm diameter fused silica capillary, 96.0 cm in total length, with 
the UV detector placed 87.5 cm from the inlet.  Experiments were done in cationic mode 
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(the anode at the inlet and cathode at the outlet).  Samples were run at a concentration 
of 2 mM in 17 mM PBS (phosphate buffered saline, made up of 0.25% monosodium 
phosphate and 0.04% disodium phosphate) with a pH of 5.8 as in the iontophoresis 
experiments.  UV detection was measured at 195 and 240 nm and electrophoretic 
mobilities were calculated as previously described (Herr et al., 2008). 
Histology.   
After animal experiments were complete, pontamine sky blue was loaded into 
one of the empty iontophoresis barrels to mark electrode location. The dye was ejected 
by applying 40 nA of current for 20 min.  The animals were euthanized and brains were 
removed from the skull and stored in 10 % formaldehyde for at least 3 days.  Brains 
were coronally sectioned into 40-50 µm thick slices with a cryostat and visualized under 
a stereoscope equipped with a camera. 
RESULTS AND DISCUSSION 
Characterization of iontophoretic delivery in vivo 
Traditionally, iontophoretic ejection of substances with constant current has been 
considered as continuous electrical migration of an ion out of the pipette tip followed by 
diffusion into the surrounding environment (Rice and Nicholson, 1995).  Theoretical and 
experimental calculations predict that migration out of the pipette tip will be influenced by 
the prior history of the pipette including the magnitude of the retaining current applied 
and the frequency of previous ejections (Purves, 1977, 1979).  Our previous work 
showed that the iontophoretic barrels we construct have sufficiently small leakage that it 
is immeasurable by the adjacent carbon-fiber microelectrode (Herr et al., 2008).  
However, we observe that the first few ejections have diminished ejection efficiency, 
presumably due to leakage during the time for implantation and stabilization of the 
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electrode (~ 1 hour).  This is shown in Figure 3.1, where the local AP concentration was 
monitored at the peak current of its oxidation during fast-scan cyclic voltammetry as it 
was ejected into the striatum of an anesthetized rat.  The time course during 30 s 
ejections is shown in Figure 3.1(A).  The voltammetric response increases when the 
iontophoretic current is initiated.  The response continues to increase as the ejection 
continues and reaches a steady state.  If we note the exact length of each electrode, 
using a model for simple diffusion we can estimate the rise time for ejections.  
Interestingly, however, our measured-time course predicts that there is an additional 
mechanism that is slowing diffusion, which we do not fully understand.  
As shown, the time to reach a steady state is longer for the first ejection than the 
subsequent ones.  This delay is the likely cause of the “warm-up phenomenon” noted in 
previous studies where initial iontophoretic ejections elicited little to no biological 
response, but with subsequent ejections the response grew in over time (Freedman et 
al., 1975).  For this reason, before beginning biological studies, we “warm up” the 
electrode by continuously ejecting for 2-5 min into an area of the brain that is of not of 
interest.   Figure 3.1(B) shows the reproducibility of ejections after the “warm-up” period.  
Ten consecutive ejections for a single barrel show a similar steady state level when 
compared to the first ejection after the warm-up period (n = 5).  However, to take 
advantage of the finely controlled drug delivery enabled by iontophoresis, we are 
interested in monitoring the biological effects of a single 30 s ejection, and thus may not 
always reach this steady state at the site of interest, as will be evident later.   
For a substance monitored by cyclic voltammetry with the carbon fiber, the 
amplitude of the voltammetric current is expected to increase as the ejected substance 
diffuses from the ejection point down the length of the fiber and to remain constant once 
the diffusion distance exceeds the electrode length.  The concentration measured is  
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actually the average concentration along the length of the electrode determined by a 
gradient started at the iontophoretic tip, where the concentration is close to that in the 
barrel (10 mM).  For example, an electrode with a length of 30 µm (as in Figure 3.1) 
reports a current that is proportional to a uniform concentration of 3 µM across the 
surface of the electrode once steady state is reached.  When the iontophoretic current is 
turned off, the analyte quickly diffuses away from the electrode.  Within 120 s, the 
iontophoresed substance can still be detected voltammetrically, but it has diluted to a 
concentration that is ~2% of its steady-state value during ejection.   
Effects of EOF marker on stimulated dopamine release   
A common way to probe presynaptic factors that regulate neurotransmitter 
release is to examine the effects of added pharmacological agents on electrically evoked 
release (Limberger et al., 1991; Benoit-Marand et al., 2001; Phillips et al., 2002).  For 
example, the role of autoreceptors can be probed by examining stimulations before and 
after addition of receptor antagonists.  However, before the iontophoretic method was 
used with electrical stimulation to probe presynaptic events at dopaminergic terminals, 
we had to ensure that delivery of the neutral marker substances did not affect dopamine 
release.   In these experiments, AP or NPE was delivered for 30 s, followed by a wait-
period of 120 s before electrical stimulation of the medial forebrain bundle (MFB).  Figure 
3.2 shows the results of a typical experiment in a urethane anesthetized rat.  A carbon-
fiber/iontophoresis probe was lowered into the striatum and a stimulating electrode was 
lowered into the MFB.  Stimulated release (60 Hz, 40 pulses) was evoked every 120 s 
until ten consecutive maximal stimulations showed a similar maximal concentration 
(typically requiring 15 stimulations).   A representative baseline trace and color plot are 
shown in Figure 3.2(A).   To test the effects of the EOF marker on dopamine release, AP 
was iontophoretically applied for 30 s at a location that exhibited reproducible stimulated  
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Figure 3.2.  Effect of AP on stimulated dopamine release. The top panels show current 
as a function of time while the lower panels are two dimensional color plots where 
current is shown in false color on the potential vs. time axes. The white dashed lines on 
the color plots indicate the voltages at which oxidation (lower lines) and reduction (top 
lines) is occurring.   (A) A representative baseline current trace and color plot for the 
stimulated release of dopamine.  The black dashed line (t=0) indicates time of 
stimulation. (B) Representation of iontophoretic ejection of 3 µM AP.  The black dashed 
line (t=0) indicates the application of a positive current to the barrel.   (C)  Current trace 
and color plot for stimulated release after ejection seen in B.  The black dashed line (t=0) 
indicates time of stimulation.  There is no change in the extracellular concentrations of 
dopamine seen in A and C elicited with a stimulation indicated by the black dashed line 
and t=0 for each trace. 
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release.  The amount of AP delivered was monitored electrochemically, and the 
concentration vs. time trace and color plot are shown in Figure 3.2(B).  Stimulation was 
repeated 120 s after AP delivery, and the maximum amplitude of released dopamine and 
its time course remained the same.  From the concentration of AP during its 
iontophoresis, 3 µM, we can estimate the concentration at the time of the stimulation to 
be 60 nM (2% of the steady state level).  Stimulations were continued at 2 min intervals 
for 30 min, and there was no significant change in the amount of dopamine released or 
rate of uptake (Fig 2C, n = 9, p > 0.01).  The same experiment was performed for NPE, 
with no measurable difference observed from control (n=4, p > 0.01).   
Current artifacts on stimulated dopamine release 
It is often noted in iontophoretic literature that current artifacts can be seen 
neurophysiologically due to the introduction of Na+ and Cl- that are in the drug solution 
(Curtis and Nastuk, 1964; Stone, 1985).  Although in our experiments we are not 
monitoring cell firing, and are instead monitoring presynaptic release of dopamine, we 
wanted to ensure that current artifacts were not affecting our measured results.  For 
these experiments, just as in the previous set of experiments, we adjusted the position of 
the carbon-fiber/iontophoresis assembly so that it was in a location in the striatum that 
showed robust dopamine release.  After establishing reproducible stimulated release of 
dopamine, we iontophoretically ejected NaCl (5 mM in the barrel, made up in deionized 
water) for 30 sec.  Although NaCl is not electroactive, by applying a large constant 
current (greater than 100 nA) we are able to detect a change in our background signal 
(~4 nA in this example) that evolves with time (Figure 3.3).  The current is an indirect 
effect of the iontophoresis and its time course indicates that it reflects a change in the 
electrical double layer formed at the carbon fiber electrode.  While we cannot quantify 
the amount of NaCl delivered from this signal, it does serve to confirm that ejection 
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occurred.  Stimulated dopamine release was then measured 120 s after the NaCl 
ejection was terminated to ensure that it did not alter presynaptic release dynamics.  The 
results from this experiment indicate that stimulated dopamine release is unaffected by 
large ejections of NaCl and are shown in Figure 3.3 (n=4, p>0.05).  The NaCl ejected 
with large currents does alter the double layer of the carbon fiber, although this is not 
seen with the lower ejection currents typically used.   
Marking of electrode placement by iontophoresis of a dye 
When dealing with small brain structures it is crucial to know the location of the 
electrode.  A common way to verify electrode placement is to remove the brain after the 
experiment is over for histology.  For experiments using carbon-fiber microelectrodes, 
one approach is to electrolytically lesion the electrode.  This has the shortcoming that 
the carbon-fiber is destroyed during this process and cannot be calibrated after the in 
vivo experiment.  An alternate approach is to remove the electrode after the experiment 
for calibration and insert a tungsten wire to electrically mark the location of the previous 
electrode.  Iontophoresis barrels provide a more convenient and precise method to mark 
electrode placement.  Figure 3.4 shows the marking of electrode placement by delivering 
pontamine sky blue dye iontophoretically for 20 min at 40 nA once the experiment was 
over.  The length of ejection was chosen to ensure that a large enough spot was 
produced, given that iontophoresis is such a localized drug delivery mechanism.  By 
using one of the empty barrels to deliver a dye, the electrode placement can be 
accurately determined while keeping the carbon-fiber intact for post-calibration.  Many 
other dyes can be used, such as alcian blue, methyl blue, fast green, and lucifer yellow, 
making the procedure compatible with any other immunohistochemistry that may be 
done post-experiment (Stone, 1985). 
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Figure 3.3.  Effect of saline on stimulated dopamine release. The top panels show 
current as a function of time while the lower panels are two dimensional color plots 
where current is shown in false color on the potential vs. time axes. The white dashed 
lines on the color plots in (A) and (C) indicate the voltages at which oxidation (lower 
lines) and reduction (top lines) is occurring, whereas in (B) the dashed white line 
indicates the potential change observed due to the ejection of NaCl.   (A) A 
representative baseline current trace and color plot for the stimulated release of 
dopamine.  The black dashed line (t=0) indicates time of stimulation. (B) Representation 
of iontophoretic ejection of saline with high applied current.  The black dashed line (t=0) 
indicates the application of a positive current to the barrel.   (C)  Current trace and color 
plot for stimulated release after ejection seen in B.  The black dashed line (t=0) indicates 
time of stimulation.  There is no change in the extracellular concentrations of dopamine 
seen in A and C elicited with a stimulation indicated by the black dashed line and t=0 for 
each trace. 
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Figure 3.4.  Confirmation of electrode placement into the striatum using iontophoresis of 
pontamine sky blue dye.  After a 20 min ejection, the spot is 600 µm in diameter.  Left 
side of the figure shows region of interest labeled and circled with a dashed line.  On the 
right, the spot from the ejection of dye can be seen in the circled region of interest. 
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Quantitative iontophoresis of non-electroactive drugs 
In our previous work, relative iontophoretic mobilities at capillary tips were 
obtained for electroactive molecules by measuring the ejected amounts at the adjacent 
carbon-fiber microelectrode (Herr et al., 2008).  We found that neutral molecules such as 
AP can be ejected, establishing a role for EOF.  We also established the role of EOF by 
demonstrating that iontophoretic and electrophoretic mobilities measured via capillary 
electrophoresis are linearly correlated, further demonstrating that at the tip of an 
iontophoresis pipette delivery is governed by both the migration of ions in an electric field 
and electroosmotic flow.   To obtain the iontophoretic mobility of electroinactive 
molecules such as the dopaminergic drugs raclopride, quinpirole, and nomifensine 
(structures shown in Figure 3.5), the electrophoretic mobility through a capillary column 
was measured with UV detection.  Retention times were used to compute the 
electrophoretic mobilities for dopamine, raclopride, quinpirole, nomifensine (all 
monocations), AP (a neutral molecule), and uric acid (a monoanion).  The 
electrophoretic mobilities were then used to compute the relative iontophoretic mobilities 
as shown in Figure 3.6.  Thus, raclopride is ejected at a rate 1.68 times as fast as AP 
whereas quinpirole and nomifensine are ejected at a rate 2.18 and 2.24 times as fast as 
AP, respectively.   With the knowledge of these ratios, the amount of an electroinactive 
molecule that is ejected can be calculated by the measured co-ejection of a neutral, 
electroactive molecule from the same barrel.  Note that the relative mobilities are in 
agreement with the expected charge computed from the relevant pKas and the size of 
the molecules. 
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Figure 3.5.  Chemical structures of compounds used for study.  Shown are compounds 
as they exist in the iontophoretic ejection solution at pH 5.8 given their pKas obtained on 
Scifinder.  All solutions were made up as 10 mM in 5 mM NaCl to ensure adequate 
electroosmotic flow and for buffering of the ionic strength. 
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 With an average ejection and an electrode with a length of 30 µm, the average 
concentration of AP across the carbon fiber is 3 µM for the example shown in Figure 3.2.  
However, the concentration at the portion of the carbon fiber closest to the iontophoresis 
tip is very near that placed inside the barrel (10 mM).  Such high concentrations of drug 
could alter the sensitivity of the electrode to dopamine.  To evaluate this, we first 
calibrated a series of carbon-fiber iontophoresis probes to determine their sensitivity to 
dopamine.  We then loaded one of the iontophoresis barrels with the EOF marker (AP), 
or AP plus a drug of interest.  While monitoring the response of AP with the carbon-fiber 
microelectrode, we continuously ejected the mixture into buffer for 40 min with a pump 
current sufficient to deliver approximately 10 µM of AP.  After the 40 min ejection and 
monitoring period, we calibrated the carbon-fiber electrodes’ sensitivity to dopamine 
again and determined the ratio of the electrodes’ post iontophoresis sensitivity to pre-
iontophoresis sensitivity.  The results from these experiments are presented in Table 1.  
AP and NPE, which are both neutral and can be used as EOF markers, did not 
significantly alter the electrodes’ response to dopamine.  Pharmacological agents, such 
as nomifensine, quinpirole, and raclopride, have slight effects on the electrodes’ 
response to dopamine.  Note, however, that the ejection times used during these 
iontophoresis experiments (40 min per ejection) were considerably longer than would be 
used in most in vivo experiments (normally 30 s per ejection).  Given the small effect 
observed, even with these prolonged iontophoresis conditions, the results demonstrate 
that iontophoresis of these drugs during in vivo experiments will not affect our dopamine 
measurements. 
Modulation of neurotransmitter release using quantitative iontophoresis 
Dopamine release from terminals in the striatum is regulated by D2-autoreceptors 
(Benoit-Marand et al., 2001).  Quinpirole, a D2-agonist, has been shown to decrease  
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Table 3.1.  Effect of iontophoresis on the sensitivity of carbon-fiber microelectrodes for 
dopamine detection. 
Solution Ejected by Iontophoresis  Post Ionto/Pre Ionto Sensitivity (nA/nM)  
AP 1.00 ± 0.10  
AP + NPE  1.01 ± 0.07  
AP + Nomifensine  0.86 ± 0.08  
AP + Quinpirole 0.91 ± 0.08  
AP + Raclopride 0.87 ± 0.07  
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stimulated dopamine release in slices (Kennedy et al., 1992), and we wanted to show in 
vivo modulation with iontophoretic application of quinpirole.  For these experiments we 
adjusted the position of the carbon-fiber/iontophoresis assembly so that it was in a 
location in the striatum that showed robust dopamine release (Moquin and Michael, 
2009).  After establishing reproducible stimulated release of dopamine, we 
iontophoretically ejected quinpirole and AP from the same barrel for 30 sec.  The local 
AP concentration was monitored by fast-scan cyclic voltammetry.  The stimulation was 
repeated 120 s after the iontophoretic delivery terminated when AP had diminished to ~2 
% of its concentration during iontophoretic application.  From the AP concentration we 
can calculate that the local quinpirole concentration at the time of the stimulation was 87 
nM.  This value is near the EC50 (60 nM) for quinpirole measured in brain slices (Joseph 
et al., 2002).   
Consistent with autoreceptor regulation, dopamine release was diminished 
(representative example in Figure 3.7).  This experiment was repeated in 6 different rats 
with a different iontophoretic assembly in each animal.   In these experiments the 
amount of current used for ejection was adjusted so that the same amount of AP (and 
thus quinpirole) was ejected in each animal.  The release amplitude was 63 ± 5% (n = 6) 
of its pre-drug value.  The small error associated with these measurements highlights 
the advantage of using an electroactive marker, since it allows for adjustment to the 
applied iontophoretic current so that uniform amounts of quinpirole are ejected.  Thus, 
compensation can be made for the variability inherent to each iontophoretic barrel.  
Because autoreceptors and uptake processes appear to be linked, we also examined 
the clearance rates of dopamine after stimulation.  While a trend towards faster uptake 
rates was observed after quinpirole ejections, there was not a statistically significant 
decrease in t1/2.    
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Figure 3.7.  Stimulated dopamine release in an anesthetized animal before and after a 
localized ejection of solution containing both AP and quinpirole.  The top panels show 
current as a function of time while the lower panels are two dimensional color plots 
where current is shown in false color on the potential vs. time axes.  The white dashed 
lines on the color plots indicate the voltages at which oxidation (lower lines) and 
reduction (top lines) is occurring. (A)  A representative baseline current trace and color 
plot for the stimulated release of dopamine. The black dashed line indicates the time of 
stimulation (B) Representation of iontophoretic ejection of AP and quinpirole.  The black 
dashed line (t=0) indicates the application of a positive current to the barrel. The 
measured signal is due solely to AP, and is used to estimate the concentration of 
quinpirole.  Here, 2 µM AP is the average concentration across the electrode, and is 
equivalent to 4.4 µM quinpirole. (C)  Current trace and color plot for stimulated release 
120 s after ejection seen in B.  At the time of stimulation (black dashed line), the 
concentration of AP has decreased to 2% of its original value, corresponding to a 
decrease in quinpirole concentration to 88 nM.  The extracellular concentration of 
dopamine seen in C is less than half the concentration initially seen in A.  In both A and 
C the time of stimulation is indicated by the black dashed line and t=0 for each trace. 
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Stimulations were repeated at 2 min intervals and the amplitude returned to its 
original value within 3-5 stimulations after the initial iontophoretic application.  In 
addition, when the electrode was lowered 400 µm, release similar to that seen in the 
absence of drug was observed.  Since the amounts introduced by iontophoresis are 
microscopic, it would not be expected to exert an effect over a region much larger than 
that immediately around the electrode.  It is worth noting that most iontophoresis 
experiments done previously used ejections much longer than 30 s, some delivering 
drug for 10’s of min (Cheer et al., 2007).  Such ejections seem unnecessary in light of 
the results presented here.   Indeed, the ability to make multiple injections at the same or 
different sites enables multiple concentrations of drugs to be examined in a single 
animal.  Systemic doses do not allow this type of flexibility, clearly highlighting one of the 
major advantages of iontophoresis. 
Modulation of other dopaminergic presynaptic processes 
Similar experiments were done with raclopride, a D2-receptor antagonist, which 
can block dopamine autoreceptor function, leading to an increase in release, as well as 
nomifensine, a dopamine re-uptake inhibitor that increases the amount of time required 
for dopamine to clear the synapse.  The results from these experiments showed that 
raclopride increased stimulated dopamine release to 270 ± 40% (n=5) of its pre-drug 
value.  Raclopride also caused a decrease in re-uptake rate, as indicated by the 
increased t½, from 0.63 ± 0.03 s to 0.96 ± 0.05 s.  This result is consistent with previous 
work where systemic injections of a D2-antagonist affected both release and uptake 
(Benoit-Marand et al., 2001; Wu et al., 2002) and further supports the idea that 
autoreceptor antagonists increase evoked DA levels by decreasing uptake in a complex 
signaling process.   Similarly, nomifensine delivery resulted in a 187 ± 13% increase in 
stimulated dopamine release and an increased t½ from 0.63 ± 0.03 s to 1.36± 0.05 s  
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Figure 3.8.  Stimulated dopamine release in an anesthetized animal before and after a 
localized ejection of solution containing both AP and nomifensine.  The top panels show 
current as a function of time while the lower panels are two dimensional color plots 
where current is shown in false color on the potential vs. time axes.  The white dashed 
lines on the color plots indicate the voltages at which oxidation (lower lines) and 
reduction (top lines) is occurring.  (A)  A representative baseline current trace and color 
plot for the stimulated release of dopamine. The black dashed line is the time to 
stimulation (B) Representation of iontophoretic ejection of AP and nomifensine.  The 
black dashed line (t=0) indicates the application of a positive current to the barrel.  Note 
that the measured signal is due solely to AP, and is used to estimate the concentration 
of nomifensine.  Here, 2.5 µM AP is the average concentration across the electrode, and 
is equivalent to 5.6 µM nomifensine. (C)  Current trace and color plot for stimulated 
release 120 s after ejection seen in B.  At the time of stimulation (black dashed line), the 
concentration of AP has decreased to 2% of its original value, corresponding to a 
decrease in nomifensine concentration to 112 nM.  The extracellular concentration of 
dopamine seen in C significantly increased and the clearance time is also increased, 
indicating a change in reuptake kinetics.  In both A and C the time of stimulation is 
indicated by the black dashed line and t=0 for each trace. 
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Figure 3.9.  Rapid modulation of DA autoreceptors using quinpirole and raclopride and 
dopamine transporter using nomifensine.  (A)  Stimulated release of DA is recorded 
every 120 s and plotted is the maximum amount of dopamine overflow recorded from 
each stimulation.  The circles denote the time points at which the color plots in B were 
taken.   With the application of quinpirole (Q), raclopride (R) and nomifensine (N) at the 
time represented with the vertical dashed line, there was a change in DA signal seen at 
the next stimulation.  (B)  Color plots for the stimulated release of dopamine before 
application of any drugs and after the administration of each drug.   The duration of the 
dopamine signal (white dashed line) after stimulation (black dashed line) is indicative of 
the re-uptake kinetics. 
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(Figure 3.8).  The modulations observed due to localized application of all three drugs is 
consistent with those  found for systemic injections (Kita et al., 2007).   
Rapid modulation of dopamine release and uptake 
One of the advantages of localized drug delivery is that drug effects are observed 
quickly.  Figure 3.9 demonstrates rapid modulation of dopamine release and uptake by 
using a D2 agonist, D2 antagonist, and a dopamine reuptake blocker.  Quinpirole, a D2 
agonist, was delivered to attenuate dopamine release.  As can be seen from Figure 
3.9(A), a decrease in release is observed immediately after the 30 s ejection.  In this 
representative experiment, the signal slowly returned to baseline over 10 min.  
Raclopride, a D2 antagonist, which blocks autoreceptors on dopamine terminals, quickly 
increased the amount of dopamine release observed by 3-fold.  In contrast to quinpirole, 
this effect remained steady for over 10 min.  To observe effects on dopamine uptake, we 
used the dopamine uptake inhibitor, nomifensine.  As expected from previous findings, 
the uptake blocker increased the amount of dopamine release and slowed down uptake.  
This can be seen in the color plots shown at each point of modulation in Fig 9B.  The 
dopamine signal apparent in the color plots has a longer duration once nomifensine is on 
board.  This effect, however, is shorter lived than the raclopride effect, and over the 
course of 10 min, the signal returns to what it was before nomifensine ejection.  To see if 
the raclopride and nomifensine effects could be reversed, quinpirole was re-applied, 
resulting in dopamine release returning back to the original baseline.  In addition to 
demonstrating that iontophoresis can be used to quickly and robustly modulate 
dopamine release and uptake, it also gives insight into the different rates of unbinding for 
each of these drugs.  The results show that nomifensine has a shorter-lasting effect than 
quinpirole and raclopride, consistent with studies that show nomifensine has the fastest 
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off rate from its binding site to striatal membranes (when adjusted for temperature) 
(Dubocovich and Zahniser, 1985; Dewar et al., 1989; Levant et al., 1992). 
CONCLUSIONS 
The results presented characterize and validate the use of an electroactive EOF marker 
for quantitative iontophoresis using carbon-fiber microelectrode assemblies.  Nanomolar 
concentrations of raclopride, quinpirole, and nomifensine can be delivered by monitoring 
the co-ejection of the EOF marker.  The effects of local delivery of these drugs can then 
be monitored by measuring electrically evoked dopamine release before and after drug.   
We show that a short, 30 s ejection is sufficient to affect autoreceptor regulation and 
reuptake of dopamine.  Additionally, electrode placement can be verified by 
iontophoresis of a dye, such as pontamine sky blue.  These experiments highlight the 
advantages of iontophoresis: quick, local, and selective receptor modulation.  The use of 
carbon-fiber microelectrodes and an EOF marker enables real-time measurements of 
drug delivery, eliminating confounds from faulty ejections and differences in doses. 
These modifications improve the technique of iontophoresis for in vivo 
neuropharmacological experiments. 
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Chapter 4 :  
In Vivo Electrochemical Monitoring of Electrically Evoked Extracellular 
Catecholamine in the Subregions of Bed Nucleus of the Stria Terminalis 
INTRODUCTION 
The bed nucleus of the stria terminalis (BNST) is a heterogeneous brain region 
that relays excitatory and inhibitory information from cortical, hippocampal and 
amygdalar nuclei to subcortical, hypothalamic and brainstem regions (Cullinan et al., 
1993; Dong et al., 2000; Dong et al., 2001a; Dong et al., 2001b).  Stemming from its 
anatomical positioning, various studies have explored the role of the BNST in mediating 
a host of behavioral responses ranging from fear and anxiety to addiction and reward 
(Epping-Jordan et al., 1998; Delfs et al., 2000; Erb et al., 2000; Cecchi et al., 2002; 
Sullivan et al., 2004; Fendt et al., 2005).  Dopamine (DA) and norepinephrine (NE) 
project to the BNST and have demonstrated modulatory effects on signaling in this 
region (Forray and Gysling, 2004; Meloni et al., 2006; McElligott and Winder, 2009). 
Histochemical and behavioral experiments have suggested that noradrenergic and 
dopaminergic fibers are anatomically segregated in the BNST.  However, the precise 
locations of their respective innervations within the subregions of the BNST are not 
entirely clear.   
Historically, NE fibers are thought to be found mainly in the ventral BNST (Myers 
et al., 2005).  However, emerging histochemical evidence suggests that both NE may be 
present in the dorsal lateral BNST (Egli et al., 2005), a subregion containing mostly 
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dopaminergic projections.  A caveat of any histochemical study is that they do not 
establish if the projections stained for contain functional release sites. Microdialysis 
studies provide supporting evidence that DA and NE is found within the BNST (Carboni 
et al., 2000; Cecchi et al., 2002).  However, the technique lacks the spatial resolution 
necessary to determine functional innervation of subnuclei.  Despite the important roles 
of NE and DA in the regulation of behaviors, few studies have examined in vivo release 
and uptake of NE and DA in the subregions of the BNST.  This is, in part, because 
BNST subregions containing appreciable amounts of NE or DA are often only a few 
hundred microns across, thus requiring techniques with high spatial resolution and 
sensitivity (Park, 2009).  Additionally, BNST subnuclei reside is close proximity to the 
striatum, ventral pallidum (VP), and the preoptic areas (PA), all of which contain 
catecholamines (Figure 4-1). 
Previously, Park et al. demonstrated that stimulus-evoked NE release in the 
vBNST can be distinctly measured utilizing in vivo fast-scan cyclic voltammetry (FSCV) 
at carbon-fiber microelectrodes (Park, 2009).  A key advantage of this experimental 
approach is that it provides the spatial resolution necessary to selectively monitor 
catecholamines in small BNST subregions.  In addition, rapid changes (subsecond) in 
the extracellular NE concentration can be monitored in real time, allowing critical 
differences in the dynamics of release and uptake amongst the BNST subregions to be 
probed.   
Here, DA and NE are individually monitored in distinct subregions of the BNST 
using FSCV, with pharmacological verification and micro-lesioning of the recording site.  
Results show that the majority of functional noradrenergic projections are limited to the 
dorsomedial BNST with the largest projection innervating the subcommisural ventral 
BNST near the fusiform and parastrial subnuclei. Conversely, the dopaminergic 
projections are mainly distributed in the dorsolateral (dl) BNST near the oval subnucleus.  
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Figure 4.1.  Anatomical location of BNST subnuclei.  Shown is a depiction of a coronal 
slice of a rat brain.  The BNST spans a little over 1 mm in the medial-lateral axis, and 
about 1.7 mm in the dorsal-ventral axis.  It is divided into dorsal and ventral regions by 
the anterior commisure (ac).  The subregions examined in this study are the dlBNST 
(orange), dmBNST (dark blue), and mvBNST (green).  The lvBNST (purple) was not 
studied in this study, but does show some catecholamine release. Thus, the mvBNST 
will be referred to as the vBNST. Regions shown in light blue are neighboring sites that 
contain catecholamines and can confound results if the appropriate anatomical and 
pharmacological verifications are not done.     
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Using quantitative iontophoresis we compare the pharmacological effects of 
catecholaminergic receptor antagonists and uptake blockers administered i.p. with those 
delivered locally in the subregion of interest.  Use of quantitative iontophoresis provided 
pharmacological evidence that modulation of release in the ventral-medial BNST occurs 
through presynaptic mechanisms, but modulation in the dorsal-medial occurs through a 
combination of mechanisms.   
MATERIALS AND METHODS 
Chemicals and drugs  
Unless noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO) 
and used as received. Chemical structures of the species used are shown in Appendix I.  
Solutions were prepared using deionized water.  A physiological buffer solution, pH 7.4, 
(15 mM TRIS, 126 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 2.4 mM CaCl2, 1.2 mM 
NaH2PO4, 1.2 mM MgCl2, 2.0 mM Na2SO4) was used in all calibration experiments.   
Desipramine-HCl, raclopride-HCl, and idazoxan-HCl were dissolved in saline.  
GBR 12909-HCl was dissolved in double distilled water and then diluted with saline 
Animals and surgery   
Male Sprague-Dawley rats (225-350g; Charles River, Wilmington, MA) were 
anesthetized with urethane (1.5 g/kg, i.p.) and placed in a stereotaxic frame (Kopf, 
Tujunga, CA).  Holes were drilled in the skull on the right hemisphere for the working and 
stimulating electrodes at coordinates selected from the atlas of Paxinos and Watson 
(Paxinos and Watson, 2005).  An Ag/AgCl reference electrode was inserted in the left 
hemisphere.  The carbon-fiber iontophoresis probe was placed either in the either the 
medial (+1.2 mm ML, 0 AP from bregma) or lateral BNST (+1.6 mm ML, 0 mm AP from 
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bregma).  The stimulating electrode was placed in the VTA (+1.0 mm ML, -5.2 mm AP 
from bregma).  The carbon-fiber and stimulating electrodes were individually adjusted in 
the dorsal-ventral coordinate to locate the optimal locations for stimulated NE release.   
Electrical Stimulation   
An untwisted bipolar stimulating electrode (Plastics One, Roanoke, VA) was used 
to stimulate catecholamine neurons using a pair of linear constant current stimulus 
isolators (model NL80A, NeuroLog System, Digitimer Ltd, UK).  The stimulation train 
consisted of 40 biphasic pulses (± 300 µA, 2 ms/phase) applied at 60 Hz.  The pulses 
were generated by a computer and applied between the cyclic voltammograms to avoid 
electrical interference.   
Iontophoresis Probes   
A glass capillary (Part # 624503, 0.60 mm o.d., 0.4 mm i.d., 4” long, A-M 
Systems, Sequim, WA) was loaded with a carbon fiber (T-650, Thornel, Amoco Corp., 
Greenville, SC) that served as the working electrode.  This capillary containing the 
carbon fiber was then inserted into one barrel of a 4-barrel capillary (Part # 50644, 1 mm 
o.d., 0.75 mm i.d., 4barrel GF pipettes, 4” long, Stoelting Co., Wood Dale IL).  The four 
barrel assembly contained glass filaments (GF) in each barrel that aid in filling the barrel 
by capillary action.  The capillaries were bundled together with heat shrink and tapered 
to a sharp tip using a micropipette puller (Narashige, Tokyo, Japan) with a two-step pull 
process.  The protruding carbon fiber was cut to a length between 30 and 50 µm by 
careful use of a scalpel under a 10X microscope objective.  The resulting probe consists 
of a glass-encased carbon fiber that is 5-7 µm in diameter and 3 iontophoretic barrels 
each about 1 µm in diameter.  Before use, the barrel containing the carbon fiber was 
backfilled with electrolyte (4 M potassium acetate, 150 mM potassium chloride) and fitted 
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with wires for electrical contact.  The remaining barrels for iontophoresis were filled with 
solutions containing reagents to be ejected.   
Electrochemical Data Acquisition and Presentation  
Cyclic voltammograms were acquired using data-acquisition hardware and 
locally software written in LabVIEW (National Instruments, Austin, TX). The cyclic 
voltammetry waveform was generated and the voltammetric signal was acquired with a 
computer interface board, the PCI-6052E (National Instruments). A PCI-6711E D/A 
board (National Instruments) was used to synchronize waveform application, data 
acquisition, and to trigger the iontophoretic current applied and the loop injector in the 
flow injection apparatus. The voltammetric waveform was input into a custom-built 
instrument for application to the electrochemical cell and current transduction (University 
of North Carolina at Chapel Hill, Department of Chemistry Electronics Facility).  After 
data collection, background subtraction, signal averaging, and digital filtering (low pass 
filtered at 2 kHz) were all done under software control.  
For all experiments, a triangular waveform was applied with a scan rate of 400 V 
s-1 with a rest potential of -0.4 V versus a Ag/AgCl reference electrode between scans, a 
linear scan to 1.3 V, followed by a scan back to the rest potential.  The scans were 
repeated every 100 ms, and collection was typically for 15- 60 s.  This large amount of 
data is presented as a color plot, with the applied voltage plotted on the ordinate, time on 
abscissa, and measured current in false color. 
Iontophoresis Ejections   
Each barrel of the iontophoresis assembly was filled with the drug of interest and 
the EOF marker, usually AP, at concentrations of ~10 mM in 5 mM NaCl at pH 5.8.  
Injection currents were delivered by a constant current source designed for 
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iontophoresis (Neurophore, Harvard Apparatus, Holliston, MA).  For each barrel, an 
ejection current (between 5 to 40 nA) was selected by evaluating ejections (30 s 
duration) that gave a measurable voltammetric signal for the EOF marker (average peak 
current of 5 to 30 nA at the peak potential in the voltammogram).   A current of 0 nA was 
applied between ejections.   
Calibrations 
The response of the carbon fiber electrode was calibrated in a flow injection 
analysis system after in vivo use, unless the electrode was used for lesioning 
(Kristensen et al., 1986).  The probe was positioned at the outlet of a six-port rotary 
valve.  A loop injector was mounted on an actuator (Rheodyne model 7010 valve and 
5701 actuator) that was used with a 12-V DC solenoid valve kit (Rheodyne, Rohnert 
Park, CA) to introduce the analyte to the surface of the electrode. The linear flow velocity 
(1.0 cm s-1) was controlled with a syringe infusion pump (Harvard Apparatus model 940, 
Holliston, MA).  The voltammetric current was measured at the peak potential for each 
analyte that was evaluated at 4 concentrations.  For carbon-fiber microelectrodes used 
to lesion the brain (see below), we used a postcalibration factor (9.3 ± 0.5 nA/µM for 
dopamine, 6.0 ± 0.2 nA/µM for norepinephrine), based on the average response 
obtained from multiple electrodes as described in our previous study. 
Capillary Electrophoresis Experiments 
A home-built CE system equipped with an absorbance detector and a 30 kV 
power supply was employed.  Absorbance traces were collected using a custom written 
LabVIEW program (Courtesy of Professor James Jorgensen, UNC-CH).  Separations 
were carried out in a 50 µm diameter fused silica capillary, 96.0 cm in total length, with 
the UV detector placed 87.5 cm from the inlet.  Experiments were done in cationic mode 
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(the anode at the inlet and cathode at the outlet).  Samples were run at a concentration 
of 2 mM in 17 mM PBS (phosphate buffered saline, made up of 0.25% monosodium 
phosphate and 0.04% disodium phosphate) with a pH of 5.8 as in the iontophoresis 
experiments.  UV detection was measured at 195 and 240 nm and electrophoretic 
mobilities were calculated as previously described (Herr et al., 2008). 
Histology   
At the end of experiments, electrode placements were verified by electrolytic 
lesions made with the carbon-fiber microelectrodes and killed with an overdose of 
urethane (2.0 g/kg) as described previously (Garris and Wightman, 1994; Park et al., 
2009).  A lesion was made at the recording site by applying constant current (20 µA for 
10 s) to the carbon-fiber electrodes.  Brains were removed from the skull and stored in 
10 % formaldehyde for at least 3 days, and coronally sectioned into 40 µm thick slices 
with a cryostat.  The sections mounted on slides were stained with 0.2 % thionin, and 
coverslipped before viewing under a light microscope.   
RESULTS AND DISCUSSION 
Catecholamine detection within the BNST 
Figure 4.1 shows a coronal cross section of the BNST, highlighting the major 
subnuclei and the neighboring catecholaminergic sites.  The BNST spans approximately 
1 mm in the medial/lateral axis and approximately 1.5 mm on the dosal/ventral axis 
including the anterior commissure, which transects the BNST dividing it into dorsal and 
ventral portions.  Although histochemical and microdialysis evidence exists indicating 
that DA an NE are present in regions of the BNST, mapping of the subregions using 
voltammetric techniques with high spatial resolution has not been done.  In Figure 4.2, 
mapping of catecholamine release is shown for both ventral and dorsal regions in the  
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Figure 4.2  Anatomical mapping of catecholamine releasing sites in the medial and 
lateral BNST. (A, B). Electrical lesioning provides histological evidence that the electrode 
was positioned in the dorsomedial and ventral medial (A) or dorsolateral (B) BNST.  
(C,D) The BNST is divided into dorsal and ventral regions by the anterior commissure.  
Mapping of catecholamine release on the dorsal-ventral axis shows that in the medial 
BNST, the most robust signal is observed ventral to the commissure, although some 
catecholamine release is observed in the dorsal region.  Conversely, in the lateral BNST, 
a measurable catecholamine signal is observed dorsal to the commissure.   
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BNST.  Catecholamine release was evoked by lowering a bipolar stimulating electrode 
into the VTA/SN to stimulate dopamine cell bodies and passing noradrenergic fibers.  A 
carbon-fiber microelectrode was lowered into either the medial (+1.2 mm ML, 0 AP from 
bregma) or lateral BNST (+1.6 mm ML, 0 mm AP from bregma) to measure release.  
Electrodes placed in the dorsomedial (dm) BNST revealed a slow rising current that 
appeared at approximately 6.0 mm from the skull surface, and was most robust in the 
ventral (v) BNST at approximately 7.5 mm from the skull near the parasagital and 
fusiform subnuclei. The current was not observed around 7.0 mm from the skull surface 
due to the electrode passing through the anterior commissure. Positioning the electrode 
in the dorsolateral (dl) BSNT revealed a characteristically distinct current from the medial 
position that was most robust at approximately +6.5 mm from the skull close to the oval 
and juxtacapsular subnuclei. This current showed a faster rise time, similar to signals 
observed when measuring DA in the striatum.  
Pharmacological evidence for NE in the ventral BNST and DA in the 
dorsolateral BNST 
The identity of the signals shown in Figure 4.3 cannot be determined based on 
qualitative assessment of the voltammetric signal.  DA and NE exhibit similar 
electrochemical properties; thus their cyclic voltammograms are indistinguishable, as 
shown in Figure 4.3.  However, selective NE or DA drugs can be used to distinguish the 
signals since pharmacology is an established criterion for determining the identity of a 
neurotransmitter.  Idazoxan (IDA), an α2-andrenergic antagonist and desipramine (DMI), 
a NET inhibitor were used to probe the contribution of NE to the signals measured.  
Conversely, raclopride, a D2 antagonist, and GBR 12909, a selective DAT inhibitor, 
were used to determine if the signal was dopaminergic or noradrenergic.   
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Figure 4.3.  Cyclic voltammograms of dopamine and norepinephrine.  Catecholamines 
are structurally and electrochemically similar.  Cyclic voltammograms obtained for a 1 
µM injection of DA (solid line) and NE (dashed line) are shown.  While there is a slight 
offset between oxidation potential of DA and NE, it is not sufficient to qualitatively 
distinguish the signals.  It is also important to note the differences in sensitivity for DA 
and NE.  The current due to the oxidation of NE is nearly 4Xs less than that measured 
for DA oxidation.  This significant decrease in sensitivity adds to the difficulty in 
monitoring NE in vivo. 
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The vBNST and dlBNST showed the greatest amount of catecholamine release, 
and thus these regions were chosen for pharmacological verification.  After establishing 
reproducible catecholamine release, systemic injection (i.p.) of NE and DA drugs were 
given.  NE drugs IDA (5 mg/kg) and DMI (15 mg/kg) increased the current and decay 
time (respectively) of stimulated catecholamine release in the vBNST but not in the 
dlBNST. Conversely, the DA drugs raclopride (2 mg/kg) and GBR 12909 (15 mg/kg) 
increased the current and half-life time (t1/2), respectively, of stimulated catecholamine in 
dlBNST but not the vmBNST.  The half-life of catecholamine uptake, t1/2, was taken as 
the time to descend from its maximum value to half of that value.  These data indicate 
that NE is the major catecholamine present in the vBNST, while DA is present in the 
dlBNST.   The results from these experiments are shown in Figure 4.4. 
Time course of catecholamine response within the BNST 
A closer examination at the DA and NE signals measured in the BNST reveal 
interesting aspects about the nature of catecholamine release in this region.  First, the 
t1/2, which is indicative of re-uptake kinetics is approximately twice as long for NE release 
in the vBNST as compared to DA release in the dlBNST (t1/2 norepineprhine: 1.36 + 
0.07; t1/2 dopamine: 0.67 + 0.05; n=6).  Moreover, NE re-uptake in the dmBNST (2.37 + 
0.07, n = 5) is slower than in the vBNST.  Surprisingly, following the onset of stimulation 
there is approximately a 260 ms time delay prior to the increase in current due to NE 
release that is not observed with DA (Figure 4.5).  Neither the differences in the current 
decay time, nor the delay in stimulus onset can be attributed to the kinetics of the 
electrochemical reaction at the electrode surface as confirmed by in vitro experiments.  
Thus, the observed delay must have a physiological meaning that could reveal 
interesting and unique aspects of NE neurotransmission.  While NE release and uptake 
in vivo are just beginning to be explored in the field, DA release and uptake have been  
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Figure 4.4.  Identification of catecholamine signals with pharmacology.  (A)  NE drugs 
desipramine and idazoxan  do not modulate electrically evoked catecholamine release in 
the dlBNST, but DA drugs raclopride and GBR12909 do modulate release in dlBNST 
(B).  Conversely, NE drugs desipramine and idazoxan modulate release in the vmBNST 
(C) but not in the dlBNST (D).   These data indicate the catecholamine signal measured 
in the vmBNST is NE, and DA in the dlBNST. 
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Figure 4.5.   NE and DA show different rise times after electrical stimulation.  Current 
versus time traces for NE and DA are shown in (A) due to electrical stimulation (red 
boxes indicate start and finish of stimulation).  The green box indicates the delay in rise 
time present from NE traces.  However, in vitro, NE and DA exhibit the same time-
response at the electrode (B), thus the observed delay in vivo must have a physiological 
basis that may hint at signaling differences between NE and DA. 
0.5 s
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extensively studied in brain slice and in in vivo.  The body of this work has shown that 
the shape of the current reveals important aspects of the kinetics of release and uptake.  
Thus, the characteristic differences in rise time and clearance of DA and NE may be 
indicative of differential modes of neurotransmission. 
Local regulation of norepinephrine release in the BNST with quantitative 
iontophoresis 
As demonstrated above, blocking NE’s activation of the α2-adrenergic receptors 
with a systemic injection of antagonist increases the observed concentration of NE 
release upon stimulation of noradrenergic fibers. This result fails to demonstrate, 
however, if the α2-AR’s control over noradrenergic transmission is at the synaptic 
terminals within the BNST or a global systemic effect.  Although work done in BNST 
slices has shown that α2-adrenergic receptors regulate NE release, presynaptic 
regulation of NE has not been demonstrated in vivo.  Previous work has demonstrated 
that quantitative iontophoresis can be used to locally modulate dopaminergic release in 
vivo (Chapter 3). Thus, to examine presynaptic regulation of NE release, we used 
quantitative iontophoresis to locally apply selective NE drugs at BNST terminals.  The 
vBNST and dmBNST, which show stimulus evoked NE release, were chosen as the 
target for these studies since both lie on the same anterior-posterior axis simplifying the 
experimental design. 
Iontophoresis of acetaminophen has no effect on NE release in the medial 
BNST 
Quantitative iontophoresis is accomplished by voltammetrically monitoring 
ejection of an electroactive neutral substance that serves as a marker for electroosmotic 
flow (EOF), the main source of variability in ionotophoretic ejections.  Acetaminophen 
was chosen as the EOF marker for these experiments since it has been previously 
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shown to have no effect on neurotransmission in the striatum (see Chapter 2).  However, 
the effects of acetaminophen iontophoresis into the BSNT have not been examined and 
thus needed to be tested before use with pharmacologically active drugs.  Figure 4.6 
shows that acetaminophen iontophoresis has no observable effect on the amplitude or 
kinetic of NE release in the BNST.  As in the above experiments, the position of the 
carbon-fiber microelectrode was adjusted dorsal/ventrally to locate robust NE release.  
After establishment of a steady baseline, acetaminophen was iontophoretically delivered 
for 30 s.  Confirmation and quantification of this ejection can be seen from the current v. 
time trace in Figure 4.6(B).  After iontophoretic delivery was determined, 120s elapsed to 
allow to the electrochemical signal to return to baseline, at which stimulation was 
repeated.  No observable change in the amplitude or kinetics of NE release was 
observed, establishing that acetaminophen can be used as an internal marker in the 
BNST for quantitative iontophoresis. 
Quantification of iontophoretic delivery of electroinactive NE drugs 
To determine the relative mobility of NE drugs IDA and DMI, capillary 
electrophoresis was used.  As has been previously shown, electrophoretic mobilities 
obtained from capillary electrophoresis are positively correlated to the rate of 
iontophoretic transport relative to an electroosmotic flow (EOF) marker (Herr et al., 
2008).  Briefly, much like capillary electrophoresis, iontophoretic delivery is due to the 
combination of ion migration and EOF.  Use of a neutral electroactive marker allows 
EOF to be directly monitored using carbon-fiber microelectrodes coupled to iontophoretic 
barrels.  Differences in electrophoretic mobility indicate the relative rate of migration for 
ions within a single run.  The rates of transport for DA and uric acid relative to 
acetaminophen have been previously determined in both capillary electrophoresis and 
iontophoresis (Herr et al., 2008). This data demonstrated that there is a positive  
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Figure 4.6.   Effect of AP on stimulated NE release in the vBNST. The top panels show 
current as a function of time while the lower panels are two dimensional color plots 
where current is shown in false color on the potential vs. time axes. The white dashed 
lines on the color plots indicate the voltages at which oxidation (lower lines) and 
reduction (top lines) is occurring.   (A) A representative baseline current trace and color 
plot for the stimulated release of dopamine.  The black dashed line (t=0) indicates time 
of stimulation. (B) Representation of iontophoretic ejection of 3 µM AP.  The black 
dashed line (t=0) indicates the application of a positive current to the barrel.   (C)  
Current trace and color plot for stimulated release after ejection seen in B.  The black 
dashed line (t=0) indicates time of stimulation.  There is no change in the extracellular 
concentrations of NE seen in A and C elicited with a stimulation indicated by the black 
dashed line and t=0 for each trace. 
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correlation between the two.  Thus, to quantify iontophoretic delivery of electroinactive 
drugs electrophoretic mobilities will be used to calculate the relative iontophoretic rate of 
delivery.   The results from this experiment are shown in Figure 4.7.  The data indicate 
that DMI and IDA are transported at rates that are 2.21 and 2.42 times as fast as the 
EOF marker, acetaminophen, respectively.  These rates will be used to calculate the 
amount of IDA and DMI delivered when co-ejected with an EOF marker. 
Iontophoresis of NE drugs in dorsal and ventral portions of the medial BNST 
The effects of DMI and IDA were evaluated in the dmBNST and vBNST.  Since 
iontophoresis allows for multiple drugs and sites to be evaluated in one animal, the 
effects of both drugs were first investigated in the dmBNST followed by the vBNST.  
Stimulated release of NE was first established in the dmBNST. Following pre-drug 
control measurements, IDA was iontophoretically applied for 30s.  At steady state, the 
concentration of IDA at the electrode was 12 µM based on the measured acetaminophen 
concentration and the values obtained from Figure 4.7.  Stimulation of noradrenergic 
fibers was repeated every 120s after iontophoretic application. Previous work has shown 
that 120s after the termination of ejection, the electrochemical signal observed due to 
ejection is diminished to ~2% of its steady-state value (Herr et al., 2008).  Thus, at the 
time of stimulation the concentration of IDA present is ~ 240 nM.  Identical experiments 
were done with DMI, after the IDA drug effect was evaluated and with both drugs in the 
vmBSNT.   An example of these experiments is given in Figure 4.8 showing the effect of 
IDA on stimulated NE release in the vmBNST.  Across animals in the dmBNST, neither 
IDA nor DMI had an effect on the amplitude of stimulated NE release.  DMI did have an 
effect on re-uptake kinetics with an increase of 123 + 3 % from the pre-drug value.   
Conversely, in the vBNST, both drugs had significant effects on the release and 
clearance of NE.  Following IDA application, the measured NE overflow was 179 + 25 %  
110 
 
 
 
 
 
Figure 4,7.  The electrophoretic mobilities of the electroactive compounds uric acid, AP, 
and DA (■) are positively correlated to previously reported iontophoretic rates.  The 
linear regression from this correlation was used to determined iontophoretic rates 
relative to AP for desipramine (D) and idazaxon (I) (□) based on their electrophoretic 
mobilities calculated by capillary electrophoresis.   
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Figure 4.8.  Stimulated NE release before and after a localized ejection of solution 
containing both AP and idazaxon.  Shown is the current as a function of time at the 
oxidation potential for NE. (A) A representative baseline current trace for the stimulated 
release of NE. The red boxes indicate the beginning and end of stimulation (B) 
Representation of iontophoretic ejection of AP and idazoxan.  The measured signal is 
due solely to AP, and is used to estimate the concentration of idazoxan.  Here, 5 µM AP 
is the average concentration across the electrode, and is equivalent to 12 µM idazoxan. 
(C)  Current trace for stimulated release 120 s after ejection seen in B.  At the time of 
stimulation (red square), the concentration of AP has decreased to 2% of its original 
value, corresponding to a decrease in idazoxan concentration to 240 nM.  The 
extracellular concentration of NE seen in C is significantly increased from that observed 
pre-drug. 
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of pre-drug value.  DMI also increased stimulated NE release to 175 + 21 % of the pre-
drug value and had an effect on re-uptake giving an increase of 405 + 145 % in t1/2. 
The dorsal and ventral portions of the BNST are differentially modulated by 
iontophoresis of desipramine and idazoxan 
Drug effects of DMI and IDA on the vmBNST are consistent with drug effects 
following systemic (i.p.) injection.  Interestingly, the average increase in NE release 
observed by iontophoretically and systemically delivered were not statistically different.  
This suggests that in our preparation regulation of NE by α2-andrenergic receptors in the 
vBNST is controlled at the terminal regions.    The effects of systemically delivered DMI 
increased NE release significantly more than iontophoretically applied DMI. However, 
this is likely due to the fact that systemically administered DMI followed systemic 
administration of IDA, which had not completely washed out.  In contrast, iontophoresis 
drug effects are short-lived, with drug effects typically lasting only 10s of min.  Thus, the 
effects of DMI iontophoresis were not compounded by application of IDA, and could 
explain the decreased effect observed.    
The results from IDA iontophoresis in the dmBNST revealed no effect on NE 
release, in contrast to systemic (i.p.) injection of IDA which revealed a significant 
increase in release.  This apparent contradiction of results could have several origins.  
First, it is possible that significantly different doses reached the receptors by systemic 
and iontophoretic delivery.  Although we can accurate report the injected dose, it is 
difficult to know the dose present within the BNST following i.p. injection.  Therefore, it is 
possible that the systemic dose at the receptors is significantly higher than that given 
iontophoretically.  However, given the nature of iontophoretic delivery, this seems 
unlikely, since iontophoretic doses are traditionally on the high side as compared to 
EC50’s determined through slice work (Herr et al., 2008).    Indeed, the concentrations of 
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IDA achieved in the dmBNST were identical to those iontophoretically delivered in the 
vmBNST where significant increase in release was seen. An alternative and more likely 
explanation is that the observed drug effects from systemic i.p. injection are global and 
indicate that regulation of NE does not occur at terminal fields in the dmBNST.  Instead, 
NE regulation may be due to activation of α2-andrenergic receptors found on input 
neurons to the BNST that also modulate NE release (Shields et al., 2009).  This is 
supported by the finding that α2-andrenergic receptors are expressed ubiquitously in the 
brain, and are present on several brain regions that send inputs to the BNST.  
Similar to the vmBNST, the effects of iontophoretically applied DMI are 
consistent with those observed due to systemic injection.  This is not surprising since the 
role of NET is to control clearance locally and is not hypothesized to regulate release 
globally.  Thus, the combination of systemic injections and iontophoresis suggest that 
NE release in the vmBNST is primarily controlled at the terminals by α2-andrenergic 
receptors and NET.  Control in the dmBNST appears to be more complicated, relying on 
a combination of terminal regulation by NET and possible global regulation by α2-
andrenergic receptors. 
Iontophoresis as a diagnostic tool for the identification of catecholamine 
signals 
During the course of the experiments it became apparent that iontophoresis 
could be used to quickly determine if the catecholamine signal being measured was 
noradrenergic or dopaminergic.  In some animals, although the placement of the carbon-
fiber iontophoresis probe was intended for the vmBNST, micro-lesioning after the 
experiment demonstrated that the electrode was partially placed in the striatum.  Thus, 
the signal measured was a mixture, mostly containing DA.  Iontophoresis of NE drugs in 
these animals caused no change in release.  Due to the fast kinetics of the signal and 
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the ineffectiveness of NE drugs, DA contamination was suspected.  This was verified by 
iontophoresis of DA drugs raclopride and GBR 12909 which significantly increased 
release.  While this same pharmacological evaluation can be done with systemic drug 
injections, the advantage of using iontophoresis is 2-fold.  First, iontophoretic drug 
delivery quickly modulates release.  Drug effects are observed within a few minutes of 
delivery, and levels typically return to pre-drug values within 10-20 minutes.  Second, 
and more importantly, the localized nature of iontophoretic drug delivery renders areas 
beyond ~100 µm from the release site drug-naïve.  Therefore, if it is determined that 
there is contamination from other brain regions, the electrode can be adjusted, and the 
experiment continued without concern of lingering drug effects.  Thus, although not the 
focus for this current study, this is a powerful use of iontophoresis, since a limiting factor 
in studying subregions in the BNST is the frequency with which the correct brain regions 
are targeted.  
CONCLUSIONS 
The results presented demonstrate that catecholamine release can be monitored 
in the subregions of the BNST vBNST, dmBNST, and dlBNST.  Pharmacological 
characterization indicates that NE is the catecholamine found in vBNST and dmBNST 
while DA is in the dlBNST.  Additionally, quantitative iontophoresis was used in the 
vBNST and dmBNST to demonstrate regulation of NE by α2-andrenergic receptors and 
NET.   The unique experimental approach of using quantitative iontophoresis coupled to 
fast-scan cyclic voltammetry revealed that regulation by α2-andrenergic receptors is 
different in the vBNST than dmBNST.  This interesting and novel result highlights the 
advantage of using iontophoresis to investigate terminal control of neurotransmission. 
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Chapter 5 
 
Adaptation of quantitative iontophoresis to study neurotransmission 
during reward-seeking behaviors 
INTRODUCTION 
 The positive reinforcing actions of drugs of abuse serve as the basis for many 
animal models of addiction.  For example, animals can be trained to perform several 
tasks (e.g., pressing a lever) for drugs that have high abuse potential in humans (e.g., 
cocaine, amphetamine).  The reinforcing properties of drug linearly correlate with how 
well animals perform the task, and how complex of a task they will perform (Koob, 1995).  
Similar to drugs of abuse, electrical stimulation of certain brain regions has positive 
reinforcing actions (Olds and Milner, 1954).  In fact, self-stimulation by animals (termed 
intracranial self-stimulation (ICSS)) displays stronger reinforcement than some drugs of 
abuse, as indicated by the time it takes an animal to learn the behavior.  Additionally, it 
has been shown to activate common pathways as drugs of abuse, and thus serves as a 
good model to study brain regions involved in reward-seeking.   
 Animals strongly support ICSS for dopamine (DA) neurons found in the ventral 
tegmental area (VTA) and its projection through the medial forebrain bundle (MFB), 
implicating this pathway in reward-seeking (Olds and Olds, 1963; Cooper and Breese, 
1975; Wise, 2004).  DA neurons from the VTA form synapses on medium spiny neurons 
(MSNs) in the nucleus accumbens (NAc), to form part of the mesolimbic DA system.  
Studies have shown that during reward-seeking behaviors, neurons in the VTA are 
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transiently activated and levels of DA in the NAc are increased (Phillips et al., 2003; 
Roitman et al., 2004; Cheer et al., 2007a; Day et al., 2007).  However, what remains less 
clear is the exact role of DA during these behaviors, and the mechanisms by which DA 
modulates output signals from the NAc. 
 Electrophysiology data has shown that MSNs differentially respond in the NAc to 
reward and reward-related cues, suggesting that many mechanisms may be at play.  For 
example, cues that predict the availability of a lever for ICSS or cocaine cause some 
NAc cells to increase in firing, while others decrease and some are unaffected (Carelli 
and Ijames, 2000; Cheer et al., 2007a).  These dramatically different responses suggest 
that there are microenvironments within the NAc that may be differentially modulated 
during this behavior (Carelli and Wightman, 2004).  Furthermore, using a combined 
electrochemical/electrophysiology technique, DA release from terminals has been 
correlated to measured changes in post-synaptic cell firing during ICSS and cocaine 
self-administration (Cheer et al., 2007a; Owesson-White et al., 2009).  These results 
have found that in areas of the NAc where DA release is observed in connection to 
reward-related cues, post-synaptic cells exhibit phasic activation (either excitatory or 
inhibitory).  Conversely, in areas where DA release was not observed, no activation of 
cells is seen.  Thus, DA appears to play different modulatory roles in the phasic 
activation of post-synaptic cells during reward-seeking behavior.   
 To tease apart the apparent differing roles of DA, pharmacological agents that 
can target specific receptor subtypes are needed.  Systemic injections and 
microinjection into the NAc of D1 antagonists have been shown to abolish ICSS 
behavior, while intervention with D2 antagonist does not (Cheer et al., 2007a).  This 
suggests a role for D1 in mediating DA signaling in the NAc related to reward-seeking.  
However, since systemic drug injection affects the entire system, and microinjections 
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affect an entire brain region, local difference within the NAc cannot be identified.  
Iontophoresis can be used to investigate local differences, since iontophoresis ejections 
affect a small subset of the region being studied, usually less than 100 µm from the 
delivery site.  This approach was used in combination with single-unit recordings to show 
that during ICSS, local application of the D1 antagonist, SCH23390, did not affect 
behavior but did decrease baseline and phasic firing in response to reward-related cues.  
Iontophoresis of the D2 receptor antagonist, raclopride, did not affect neuronal activity.  
These results suggest that DA signaling in the NAc during ICSS is at least partially under 
D1 receptor regulation (Cheer et al., 2007a).  A caveat of this study is that iontophoresis 
is traditionally non-quantitative, and confirmation of a successful ejection is only obtained 
through positive results.  Thus, if no effect is observed, it is difficult to definitively say 
whether the observed “no-effect” has physiological basis, or if a faulty ejection occurred.  
Although not documented, raclopride is thought of as “difficult to eject,” primarily 
because effects of the drug are rarely reproducible. 
 Recent improvements to the technique enable real-time confirmation of drug 
ejection, and quantitation of drug delivery (See Chapter 3).  Additionally, while the 
technique is traditionally coupled to electrophysiology, it has now been used to monitor 
and modulate pre-synaptic release events. These improvements will allow the role of DA 
in the NAc to be studied more definitively, and establish the involvement of D2 in DA 
signaling.  In this chapter, the improvements made to iontophoresis in Chapters 2 and 3 
will be adapted for experiments in awake and behaving animals.  While iontophoresis 
has been successfully used in awake and behaving animals in the past, this was with 
electrophysiology only.  Carbon-fiber microelectrodes can be used to simultaneously 
monitor release events and post-synaptic changes in cell firing.  This combined 
technique will be combined with iontophoresis to allow for a more complete view of the 
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role of DA in the NAc.  The main focus of this chapter will be on the adaptations done to 
date, and those still necessary to successfully transfer the use of quantitative 
iontophoresis for the studies described above. 
EXPERIMENTAL METHODS 
Animals and surgery 
 Male Sprague-Dawley rats (225-350g; Charles River, Wilmington, MA) were 
anesthetized with ketamine (10 mg/kg, i.p.) and xylazine (1 mg/kg, i.p.) and placed in a 
stereotaxic frame (Kopf, Tujunga, CA). A modified guide cannula (described in Results, 
Chapter 5, Bioanalytical Systems, West Lafayette, IL) was implanted above the NAc 
core (1.3 mm anterior, 1.3 lateral, coordinates relative to bregma) and a bipolar 
stimulating electrode (Plastics One, Roanoke, VA) was lowered to the substantia 
nigra/ventral tegmental area (VTA, 5.2 mm posterior, 1 mm lateral and 7.8 mm 
dorsoventral).  The bipolar stimulating electrode tips were 1 mm apart.  This tip 
separation allowed for centering in the VTA-region.  These coordinates assure activation 
of the neurons projecting to the NAc core (Ikemoto, 2007).  An Ag/AgCl reference 
electrode was placed in the contralateral hemisphere.   
ICSS 
Rats were trained to criterion on an FR-1 schedule, lever continuously presented. 
Following this rats were trained to lever press on a variable time-out (VTO) schedule, 
FR-1 (Figure 5.7). The VTO-schedule comprised of a maintenance and a maintenance-
delay phase. When the animal depressed the lever, a stimulus train (24 biphasic pulses, 
60 Hz, 125-150 µA, 2 ms per phase) was delivered to the stimulating electrode on 
average 150 ms later.  In the maintenance phase the lever was presented with an 
audiovisual cue for 50 trials. In the maintenance-delay phase the audiovisual cue 
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preceded lever-out by 2 s (trials 51-200).  Each trial finished after lever depression or if 
the animal failed to lever press after 15s. The inter-trial interval varied between 5 and 25 
seconds.  
Iontophoresis Probes 
 A glass tube (Part # 624503, 0.60 mm o.d., 0.4 mm i.d., 4” long, A-M Systems, 
Sequim, WA) was loaded with a carbon fiber (T-650, Thornel, Amoco Corp., Greenville, 
SC) that served as the working electrode.  This tube containing the carbon fiber was 
then inserted into one barrel of a 4 barrel capillary (Part # 50644, 1 mm o.d., 0.75 mm 
i.d., 4barrel GF pipettes, 4” long, Stoelting Co., Wood Dale IL).  The four barrel assembly 
contained glass filaments (GF) in each barrel that aid in filling the barrel by capillary 
action.  The capillaries were bundled together with heat shrink and were tapered to a tip 
of about 1 µm in diameter using a micropipette puller (Narashige, Tokyo, Japan) with a 
two-step pull process.  The protruding carbon fiber was cut to a length between 30 and 
50 µm.   
 Iontophoresis probes were secured to the animal’s head using a modified Biela 
manipulator that couples to the modified guide cannula placed in the NAc core.  Prior to 
the start of the experiment, iontophoresis probes were prepared and loaded into the 
manipulator.  Iontophoretic barrels were loaded with drug solution and fitted with 
electrical wires.  Drug solutions were made up in 5 mM NaCl at a concentration of 10 
mM at pH 5.8.  The barrel containing the carbon fiber was backfilled with electrolyte (4 M 
potassium acetate, 150 mM potassium chloride) and also fitted with a wire for electrical 
contact.   
Electrochemical Data Acquisition and Presentation 
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 Cyclic voltammograms were acquired using data-acquisition hardware and 
locally software written in LabVIEW (National Instruments, Austin, TX). The cyclic 
voltammetry waveform was generated and the voltammetric signal was acquired with a 
computer interface board, the PCI-6052E (National Instruments). A PCI-6711E D/A 
board (National Instruments) was used to synchronize waveform application, data 
acquisition, and to trigger the iontophoretic current applied and the loop injector in the 
flow injection apparatus. The voltammetric waveform was input into a custom-built 
instrument for application to the electrochemical cell and current transduction (University 
of North Carolina at Chapel Hill, Department of Chemistry Electronics Facility).  After 
data collection, background subtraction, signal averaging, and digital filtering (low pass 
filtered at 2 kHz) were all done under software control.  
 For all experiments, a triangular waveform was applied with a scan rate of 400 V 
s-1 with a rest potential of -0.4 V versus Ag/AgCl between scans, a linear scan to 1.3 V, 
followed by a scan back to the rest potential.  The scans were repeated every 100 ms, 
and collection was typically for 15- 60 s.  This large amount of data is presented as a 
color plot, with the applied voltage plotted on the ordinate, time on abscissa, and 
measured current in false color. 
Iontophoresis Ejections   
 Ejection currents were delivered by a constant current source designed for 
iontophoresis (Neurophore, Harvard Apparatus, Holliston, MA).  For each barrel, an 
ejection current (between 5 to 40 nA) was selected by evaluating ejections (30 s 
duration) that gave a measurable voltammetric signal for the EOF marker (average peak 
current of 5 to 30 nA at the peak potential in the voltammogram).   A current of 0 nA was 
applied between ejections.   
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Calibrations.  
 The response of the carbon fiber electrode in the iontophoresis probe was 
calibrated in a flow injection analysis system after in vivo use (Kristensen et al., 1986).  
The probe was positioned at the outlet of a six-port rotary valve.  A loop injector was 
mounted on an actuator (Rheodyne model 7010 valve and 5701 actuator) that was used 
with a 12-V DC solenoid valve kit (Rheodyne, Rohnert Park, CA) to introduce the analyte 
to the surface of the electrode. The linear flow velocity (1.0 cm s-1) was controlled with a 
syringe infusion pump (Harvard Apparatus model 940, Holliston, MA).  The voltammetric 
current was measured at the peak potential for each analyte that was evaluated at 4 
concentrations.   
RESULTS 
Improvements to carbon-fiber iontophoresis probe construction 
 Several challenges exist with successfully combining electrochemistry, 
electrophysiology, and iontophoresis and behaving animals.  There are many examples 
in the literature where electrophysiology and iontophoresis have been coupled for local 
modulation of cell firing (Kiyatkin and Rebec, 1996, 1997, 1999a, b; Kiyatkin et al., 2000; 
Kiyatkin and Rebec, 2000).  However, few exist where electrochemistry and 
iontophoresis have been used together, and none exist where iontophoresis has been 
used to modulate release at terminals, except for in anesthetized preparations 
(Armstrong-James et al., 1981; Cheer et al., 2007b; Herr et al., 2008).  The primary 
reason for this is that in order to obtain good, reproducible electrochemical signals, the 
integrity of the glass-carbon fiber seal must remain intact.  Carbon-fiber iontophoresis 
probe suffer from significant more fragility than traditional carbon-fiber microelectrodes.  
Because the probes consist of multiple barrels bundled together, a long, thin tapered tip 
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must be made to reduce the size of the probe area entering the brain.  This long, thin 
taper makes the tips very fragile, and in particular, the glass encasing the carbon-fiber is 
highly susceptible to breaking. 
 To reduce the fragility of the glass surrounding the carbon-fiber, an extra glass 
capillary was concentrically inserted into one barrel to provide extra structural support.  
The added glass capillary contains the carbon-fiber, and thus, the barrel that serves as 
the working electrode has extra structural support.  In addition, this also greatly reduces 
electrical cross-talk that could be detected between the carbon-fiber and the 
iontophoretic barrels when currents switched from retaining to ejecting.  Indeed, the 
commercially available multi-barrel pipettes are divided by thin glass wall that do not 
appear to have very good structural integrity.  Figure 5.1 shows electrical cross-talk 
detected at the carbon-fiber due switching the current from 0 nA to 20 nA.  The addition 
of a glass capillary to insulate the carbon-fiber has greatly reduced the occurrence of 
cross-talk, and has also generally led to more robust electrodes. 
Modification to BAS guide cannula and Biela manipulator 
 Biela manipulators fabricated by Crist Instrument Co are designed to be used 
with multi-barrel probes.  The manipulators fit probes that are 2 mm in diameter, making 
them ideal for iontophoresis probes made from 4-barrel glass, with each barrel being 1 
mm in diameter.  To couple the manipulator to the animal’s brain, they sell threaded 
hubs to which the manipulator screws onto.  The hubs are normally cemented onto the 
animal’s head, directly above a hole that has been drilled above the brain region of 
interest.  A major drawback of this approach is that during the animal’s recovery from 
surgery, a scab forms over the hole, which will block passage of the electrode.  Thus, 
before securing the manipulator to the animal’s head, the inner diameter of the hub is 
cleaned out with heparin (a blood thinner that prevents clotting) to ensure clean passage  
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Figure 5.1.  Electrical cross-talk from iontophoresis current.  In some electrodes 
electrical cross-talk was detected at the carbon-fiber microelectrode as a large change in 
current when the ejecting current was switched on and off.  (A)  Color plot showing the 
large current change due to the change in current iontophoresis current from 0 nA to 20 
nA at 5 s and 35 s. (B) Current vs time trace extracted from (A) at 0.6 V. 
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of the electrode.  Often, animals will find the cleaning of the hub painful, as a scab has 
formed over the hole.  Additionally, it is difficult to fully clean the hub, frequently causing 
electrodes to break during insertion.  For these reasons it was determined necessary to 
modify the method by which the manipulator attached to the animal’s head. 
 The Wightman lab routinely uses carbon-fiber microelectrodes to monitor DA 
release in awake and behaving animals.  For these experiments an intracerebral guide 
cannula is inserted into the brain, aimed at the brain region of interest.  Figure 5.2(A) 
shows a schematic of the canula which consists of a small diameter (~0.7 mm) polyimide 
tube attached to a hub that extends ~2 mm into the brain.  The guide tubing serves the 
purpose of directing the electrode to the targeted brain region and prevents a scab from 
forming over the drilled hole.  However, for iontophoresis probes, the guide tubing is too 
small.  A modified version of the commercially available cannula was constructed with 
larger diameter polyimide tubing (0.041”) to replace the smaller diameter tubing the 
cannulae are sold with.  In addition, a bigger hole through the hub of the cannula was 
needed.  These modifications can be done in-house, but have been contracted to the 
UNC Physics Machine shop to ensure that the polyimide tubing is cut to proper size and 
glued onto the hub as straight as possible. 
 The hub from the guide cannula in Figure 5.2 does not couple to the manipulator 
used for iontophoresis probes.  Thus, the manipulator needed to be modified or a new 
canula that does couple to the manipulator needed to be designed and built.  Both 
approaches were tried, although it was easier to modify the existing manipulator to 
couple with the cannula.  Figure 5.3 shows a drawing of the Biela manipulator used for 
iontophoresis probes.  As stated above, the manipulator screws onto a hub that is 
secured on the animal’s head.  To use the intracerebral guide cannula, an adapter piece  
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Figure 5.2.  Intracerebral guide cannulae used for experiments with awake and 
behaving animals.  (A)  Commercially available cannula as sold from Bioanalytical 
Systems, Inc.  (B) Modified cannula with wider tubing for iontophoresis probes. (Figure 
modified from http://www.basinc.com/products/iv/cannula.html) 
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Figure 5.3.  Manipulator from Crist Instruments for iontophoresis probes.  The inner 
copper chamber is designed to fit 4-barrel glass micropipettes, like that used to construct 
iontophoresis probes.  As the outer stainless steel chamber is rotated clock-wise, the 
electrode, which is secured to the inner copper chamber, moves down in a linear 
fashion, without turning.  The manipulator has a traveling distance of 23 mm, which is 
ideal for experiments targeting the NAc core at ~7 mm from the skull.  The bottom part of 
the manipulator is threaded and attaches to a threaded stainless steel hub secured onto 
the animal’s head.  To couple the manipulator to the modified guide cannula a piece that 
screws onto the bottom was machined as shown in Figure 5-4. 
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was machined by the UNC Physics Machine Shop that allows the manipulator to couple 
to the cannula hub.  A schematic with dimensions is shown in Figure 5.4. 
 In addition, to minimize breakage of electrodes during insertion into the brain 
animals are lightly anesthetized with 2% isoflurane immediately before the electrode is 
lowered.  The advantage of lightly anesthetizing animals with isoflurane is that they 
animals quickly wake up, usually within 1-2 minutes, and resume normal behavior.  This 
approach has been used in other labs performing similar experiments, and has shown 
that once the effects of anesthesia have passed, there is no significant effect on the 
animal’s ability to perform a trained behavior or on the measured DA release (Robinson 
and Carelli, 2008; Robinson et al., 2009). 
 The combination of these improvements has led to a higher success rate in 
inserting electrodes into the rat’s brain without breaking.  Challenges still exist with the 
detection of DA.  Although DA is routinely measured in awake and behaving animals 
using traditional microelectrodes, DA detection appears more difficult with iontophoresis 
probes.  There are a couple possible explanations for this.  First, it is possible that while 
the iontophoresis tips appear to be unbroken as they are being lowered into the rat’s 
brain, small cracks may be present that are not detectable by just observing the 
electrode’s background current.  Additionally, iontophoresis probes are cut to a length of 
~20-50 µm to ensure that the site being measured from is within the sphere of influence 
of iontophoretically delivered drugs.  However, signals in awake and behaving animals 
are much lower than those detected in anesthetized animals where strong electrical 
stimulations can be used (Chapters 3 and 4).  Thus, the electrode length may need to be 
increased in order to measure the lower levels detected in awake animals. 
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Figure 5.4.  Machined piece to couple Biela manipulator to intracerebral guide cannula.  
(A) Schematic of the machined piece which screws onto the bottom of the Biela 
manipulator while the top portion couples directly to the guide cannula.  (B-D) 
Dimensions of piece, given in mm.  (B) Top view, (C,D) Side views. (Schematic courtesy 
of Matt Zachek.) 
  
(A) (B)
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Modulation of DA release in awake, non-behaving animals using quantitative 
iontophoresis 
Dopamine release from terminals in the striatum is regulated by D2-
autoreceptors (Benoit-Marand et al., 2001).   For these experiments we used raclopride, 
a D2-agonist, which has been shown to increase stimulated dopamine release.  The 
position of the carbon-fiber/iontophoresis assembly was adjusted using a Biela 
manipulator to a location that showed robust stimulated DA release.  After establishing 
reproducible stimulated release of DA, raclopride and acetaminophen was 
iontophoretically ejected from the same barrel for 30 sec.  The local AP concentration 
was monitored by fast-scan cyclic voltammetry, and used to estimate the concentration 
of raclopride as described in Chapter 3.  The stimulation was repeated 60 s after the 
iontophoretic delivery terminated. 
Consistent with autoreceptor regulation, DA release was increased 
(representative example in Figure 5.5).  Measurements were repeated in 3 different 
locations from 6.8 mm to 8.0 mm from the skull.   The amount of raclopride ejected at 
each location was about the same, as indicated by the AP concentration measured 
during ejection.  The average increase in release amplitude was 125 ± 3% (n = 4 
locations) of its pre-drug value after 4 minutes.  Figure 5.6(A) shows the average time-
course of the drug effect for all locations.  Interestingly, the increase in DA release is not 
significant when all locations are averaged.  However, as shown in Figure 5.6(B), some 
of the locations show a significant increase in DA release, while other do not.  The 
heterogeneity of the drug effect within a single animal is not entirely surprising given that 
DA release within the striatum is heterogeneous.  When using a single working 
electrode, this form of drug effect heterogeneity can only be studied using iontophoresis 
since other forms of drug delivery will affect the entire brain region at once.  Thus, by the  
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Figure 5.5.  Stimulated dopamine release in an awake animal at rest before and after a 
localized ejection of solution containing both AP and raclopride.  The top panels show 
current as a function of time while the lower panels are two dimensional color plots 
where current is shown in false color on the potential vs. time axes.  The white dashed 
lines on the color plots indicate the voltages at which oxidation (lower lines) and 
reduction (top lines) is occurring. (A)  A representative baseline current trace and color 
plot for the stimulated release of dopamine. The black dashed line indicates the time of 
stimulation (B) Representation of iontophoretic ejection of AP and quinpirole.  The black 
dashed line (t=0) indicates the application of a positive current to the barrel. The 
measured signal is due solely to AP, and is used to estimate the concentration of 
quinpirole.  Here, 1 µM AP is the average concentration across the electrode, and is 
equivalent to 1.68 µM raclopride. (C)  Current trace and color plot for stimulated release 
120 s after ejection seen in B.  At the time of stimulation (black dashed line), the 
concentration of AP has decreased to 2% of its original value, corresponding to a 
decrease in raclopride concentration to 34 nM.  The extracellular concentration of 
dopamine seen in C is significantly increased over that seen in A.  In both A and C the 
time of stimulation is indicated by the black dashed line and t=0 for each trace. 
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Figure 5.6.  Time course of raclopride effect in an awake animal at rest. (A)  Plotted is 
the maximal DA overflow measured due to electrical stimulation versus time at 4 
separate locations within the same animal. At t = 65s, a 30s ejection of raclopride (light 
blue bar) was given.  Stimulation was repeated 120s, and an increase in DA release was 
observed, although not statistically significant.  The effect persists over the next 4 
stimulations.  (B) Time course at each individual location shows a similar pattern to that 
shown in (A), but it is apparent that at some locations, the drug effect is slower and 
causes less of an increase in stimulated DA release.  This finding is not surprising given 
that DA release has been shown to be heterogeneous within the striatum. 
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time the electrode is moved to another position, the effects of the drug will have already 
begun.  An alternative approach to studying drug-response heterogeneity is to use an 
array of electrodes while administering the drug systemically or locally with 
microinjection.   
Effects of raclopride on reward-related DA release 
 Animals were trained to lever press for an electrical stimulation.  A cue was 
associated with the reward, and came to predict the availability of the lever.  Figure 5.7 
shows a timing diagram of the experiment and the corresponding DA signal measured 
during the behavior.  As can be seen, a transient increase in DA is detected at the 
electrode in response to the cue that predicts the reward and the reward itself.  The 
Wightman lab has shown that the increase in response to the cue increases overtime, 
can be extinguished by removing the reward, and is reinstated once the reward is 
returned (Owesson-White et al., 2008).  Additionally, they have shown that when the 
time between trials is fixed, a DA transient can be seen before the cue, indicating that 
the animals have learned to predict the cue before it is presented.  Thus, a variable 
timeout (time between trials) is used so that the measured DA transient is due only to 
the presentation of the cue.  In this experiment, the variable time-out was increased from 
the traditional 5-25 s to 30-40 s to allow time for iontophoresis ejections in between 
trials.   
 The role of D2 was examined in this paradigm by using localized delivery with 
iontophoresis.  Systemic drug injections of D2 antagonists such as raclopride abolish 
ICSS behavior, and thus only by using localized drug delivery can the role of D2 be 
studied.  Figure 5.8 shows that local application of raclopride causes an increase in cue-
related DA transients.  Interestingly, a single 30s dose of raclopride is sufficient to cause 
the observed increase, and subsequent doses do not appear to further increase DA  
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Figure 5.7.  Timing diagram and corresponding increases in DA release during ICSS.  
Animals are trained to press a lever for an electrical stimulation to the VTA.  The 
electrical stimulation is delivered 200 ms after the lever press.  Immediately preceding 
lever extension, a houselight and tone come on that serve as a cue for the reward.  A 
variable timeout period is used because previous experiments showed that animals are 
able to predict when the lever will be presented when the cycle is repeated a regular 
interval.  The bottom traces show transient increases in DA release in response to the 
cue and the reward (electrical stimulation).  
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Figure 5.8.  Increase in dopamine signal due to cue and lever presentation.  (A) Average 
current v. time trace for 30 trials when no drug is on board, after a single 30 s 
iontophoretic application of raclopride, and after a second 30 s application.  An increase 
in cue-related DA release is seen after the first application, but no further increase is 
detected after a second application.  DA release in response to the electrical stimulation 
is not affected over the average of 30 trials by either drug application.  (B) Increases in 
cue-related DA release over the first 5 trials.  Since iontophoresis is a localized drug 
delivery tool, with fast onset of drug effect, we suspected that the majority of the drug 
effect occurred over the first few trials.  As shown, cue-related DA release is significantly 
increased after both application, but the first application shows a greater increase 
despite both doses being the same.  Additionally, the increase observed over the first 5 
trials is greater than over the average of 30 trials, indicating that the majority of the drug 
effect occurs within the first few trials.  
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release.  Also, the increase in DA is most dramatic in the first 5 trials following 
application.  While this experiment is only n = 1, it shows the utility of the experimental 
approach and provides interesting results related to dosing.  Consistent with 
anesthetized work in Chapter 3 and 4, drug effects occur quickly after a single, short 
dose.  However, it is interesting that subsequent doses do not further increase the effect.  
This appears to be a phenomenon true only for experiments in awake animals, as 
dosing experiments have been done in anesthetized animals.  Thus, while in the work of 
Cheer et al. 2007 drugs were iontophoretically delivered for 10’s of min, a short 30 s 
ejection appears to be responsible for the majority of the drug effect observed. 
Conclusions and future directions 
 The work presented in this chapter demonstrates the challenges with using 
quantitative iontophoresis for electrochemical monitoring of dopamine signaling in awake 
and behaving animals.  Improvements on probe construction and modifications to 
intracerebral guide cannulae and iontophoresis manipulators have increased the 
success rate of lowering an electrode into the animal’s brain without breaking.  However, 
detection of DA release remains a challenge, and may be due to the length of the 
electrodes used.  Future directions for this project include overcoming the challenges 
preventing routine DA detection with iontophoresis probes in awake and behaving 
animals.  Possible approaches may include further strengthening the tip of the probes 
using an insulating polymer, although care will be required to prevent the iontophoresis 
tips from being clogged. 
 Once the technique is improved sufficiently to routinely detect DA release, 
characterization of the role of D1 and D2 receptors in goal-directed behavior can begin.   
The main goal of this characterization would be to correlate differences in DA release 
and response to D1 or D2 drugs to the different populations of cells that have been 
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identified by electrophysiology (Carelli et al., 2000).  However, many other receptors and 
neurotransmitters are involved in striatal signaling, and directly or indirectly affect the 
role of DA in the striatum.  Thus, to fully understand dopaminergic signaling in the 
striatum, the roles of glutamate and acetylcholine, and their respective receptors must 
also be studied.  Iontophoresis is uniquely poised for these types of experiments since 
multiple drugs may be evaluated within a single animal.  The improvements described in 
this chapter will help further our use of iontophoresis in awake and behaving animals, 
and hopefully lead to a better understanding of dopaminergic signaling.  In addition, the 
technology can be extended to other neurotransmitter systems, such as norepinephrine 
and serotonin, and other behaviors, such as natural reward seeking. 
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